Castle Brands (ROX) 10-K/A 16 Jun 15 2015 FY Annual report (amended) Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Mar. 31, 2015	Jun. 15, 2015	Sep. 30, 2014
Document Information [Line Items]
Entity Registrant Name	Castle Brands Inc
Entity Central Index Key	1311538
Current Fiscal Year End Date	-28
Entity Filer Category	Accelerated Filer
Trading Symbol	ROX
Entity Common Stock, Shares Outstanding		157,781,544
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2015
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$86,400,000

Consolidated_Balance_Sheets

Consolidated Balance Sheets(USD ($))	Mar. 31, 2015	Mar. 31, 2014
Current Assets
Cash and cash equivalents	$1,191,603	$908,501
Accounts receivable — net of allowance for doubtful accounts of $154,434 and $204,418 at March 31, 2015 and 2014, respectively	10,550,990	8,858,146
Due from shareholders and affiliates	138,750	115,288
Inventories— net of allowance for obsolete and slow moving inventory of $267,557 and $266,473 at March 31, 2015 and 2014, respectively	21,068,241	14,650,029
Deferred tax asset	37,000	473,330
Prepaid expenses and other current assets	1,492,806	1,575,947
Total Current Assets	34,479,390	26,581,241
Equipment — net	665,373	568,395
Intangible assets — net of accumulated amortization of $6,713,774 and $6,058,005 at March 31, 2015 and 2014, respectively	7,683,227	8,178,888
Goodwill	496,226	496,226
Restricted cash	329,471	416,565
Other assets	385,253	280,195
Total Assets	44,038,940	36,521,510
Current Liabilities
Foreign revolving credit facility	34,141	20,205
Accounts payable	5,753,617	4,483,764
Accrued expenses	1,067,460	1,073,188
Due to shareholders and affiliates	1,963,883	1,936,241
Total Current Liabilities	8,819,101	7,513,398
Long-Term Liabilities
Keltic facility	10,123,544	1,953,037
Bourbon term loan (including $179,063 and $484,375 of related-party participation at March 31, 2015 and 2014, respectively)	744,900	2,015,000
Notes payable - Junior loan (including $300,000 of related party participation at March 31, 2014)	0	1,250,000
Notes payable - 5% Convertible notes (including $1,100,000 of related party participation at March 31, 2015 and 2014)	1,675,000	2,125,000
Notes payable - GCP Note	211,580	211,580
Deferred tax liability	1,370,152	1,518,304
Total Liabilities	22,944,277	16,586,319
Commitments and Contingencies (Note 14)
Equity
Preferred stock, $.01 par value, 25,000,000 shares authorized, no shares issued and outstanding at March 31, 2015 and 2014	0	0
Common stock, $.01 par value, 300,000,000 shares authorized at March 31, 2015 and 2014, 157,187,658 and 151,841,133 shares issued and outstanding at March 31, 2015 and 2014, respectively	1,571,877	1,518,411
Additional paid-in capital	162,626,893	157,485,965
Accumulated deficit	-143,361,711	-139,561,969
Accumulated other comprehensive loss	-2,285,925	-1,724,916
Total controlling shareholders' equity	18,551,134	17,717,491
Noncontrolling interests	2,543,529	2,217,700
Total equity	21,094,663	19,935,191
Total Liabilities and Equity	$44,038,940	$36,521,510

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets [Parenthetical] (USD $)	Mar. 31, 2015	Mar. 31, 2014
Allowance for doubtful accounts receivable (in dollars)	$154,434	$204,418
Allowance for obsolete and slow moving inventory (in dollars)	267,557	266,473
Accumulated amortization of Intangible assets (in dollars)	6,713,774	6,058,005
Term Loan Related Party Participation (in dollars)	179,063	484,375
Notes Payable, Related Parties, Noncurrent (in dollars)		300,000
Convertible Notes Payable Related Parties Classified Non Current (in dollars)	$1,100,000	$1,100,000
Preferred stock, par value (in dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	25,000,000	25,000,000
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	300,000,000	300,000,000
Common Stock, Shares, Issued	157,187,658	151,841,133
Common stock, shares outstanding	157,187,658	151,841,133
Convertible Notes Payable [Member]
Debt Instrument, Interest Rate, Stated Percentage	5.00%	5.00%

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Sales, net	$57,457,421	[1]	$48,140,483	[1]
Cost of sales	35,603,632	[1]	30,336,667	[1]
Provision for obsolete inventory	281,000		200,000
Gross profit	21,572,789		17,603,816
Selling expense	15,254,818		12,529,684
General and administrative expense	6,488,336		5,533,711
Depreciation and amortization	907,540		860,254
Loss from operations	-1,077,905		-1,319,833
Other income, net	16,602		0
Loss from equity investment in non-consolidated affiliate	0		-502,518
Foreign exchange loss	-4,564		-284,962
Interest expense, net	-1,129,047		-1,062,219
Net change in fair value of warrant liability	0		-5,392,594
Income tax (expense) benefit, net	-1,278,999		590,414
Net loss	-3,473,913		-7,971,712
Net income attributable to noncontrolling interests	-325,829		-935,035
Net loss attributable to controlling interests	-3,799,742		-8,906,747
Dividend to preferred shareholders	0		-384,599
Net loss attributable to common shareholders	($3,799,742)		($9,291,346)
Net loss per common share, basic and diluted, attributable to common shareholders (in dollars per share)	($0.02)		($0.08)
Weighted average shares used in computation, basic and diluted, attributable to common shareholders (in shares)	155,456,341		116,511,444
[1]	Sales, net and Cost of sales include excise taxes of $6,754,453 and $6,420,730 for the years ended March 31, 2015 and 2014, respectively.

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations [Parenthetical] (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Excise taxes	$6,754,453	$6,420,730

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Loss (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Net loss	($3,473,913)	($7,971,712)
Other comprehensive (loss) income:
Foreign currency translation adjustment	-561,009	193,178
Total other comprehensive (loss) income:	-561,009	193,178
Comprehensive loss	($4,034,922)	($7,778,534)

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Equity (USD $)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive (Loss) Income [Member]	Noncontrolling Interests [Member]
BALANCE at Mar. 31, 2013	$12,910,233	$67,013	$1,087,730	$142,661,542	($130,270,623)	($1,918,094)	$1,282,665
BALANCE (in shares) at Mar. 31, 2013		6,701	108,773,034
Net (loss) income	-7,971,712				-8,906,747		935,035
Foreign currency translation adjustment	193,178					193,178
Issuance of common stock, net of issuance costs	4,347,302		53,946	4,293,356
Issuance of common stock, net of issuance costs (in shares)			5,394,608
Conversion of series A preferred stock and accrued dividends	0	-67,013	274,656	-207,643
Conversion of series A preferred stock and accrued dividends (in shares)		-6,701	27,465,610
Exercise of common stock warrants	3,848,332		101,271	3,747,061
Exercise of common stock warrants (in shares)			10,127,123
Exercise of common stock options	25,976		808	25,168
Exercise of common stock options (in shares)			80,758
Accrued dividends - series A convertible preferred stock	0			384,599	-384,599
Reclassification of liability to equity-warrant	6,187,968			6,187,968
Stock-based compensation	393,914			393,914
BALANCE at Mar. 31, 2014	19,935,191	0	1,518,411	157,485,965	-139,561,969	-1,724,916	2,217,700
BALANCE (in shares) at Mar. 31, 2014		0	151,841,133
Net (loss) income	-3,473,913				-3,799,742		325,829
Foreign currency translation adjustment	-561,009					-561,009
Issuance of common stock, net of issuance costs	3,133,568		25,379	3,108,189
Issuance of common stock, net of issuance costs (in shares)			2,537,924
Exercise of common stock warrants	629,965		16,578	613,387
Exercise of common stock warrants (in shares)			1,657,802
Surrender of common stock in connection with exercise of common stock warrants	-31,250		-279	-30,971
Surrender of common stock in connection with exercise of common stock warrants (in shares)			-27,902
Conversion of 5% convertible notes and accrued interest thereon	451,417		5,017	446,400
Conversion of 5% convertible notes and accrued interest thereon (in shares)			501,574
Exercise of common stock options	222,984		6,771	216,213
Exercise of common stock options (in shares)			677,127
Stock-based compensation	787,710			787,710
BALANCE at Mar. 31, 2015	$21,094,663	$0	$1,571,877	$162,626,893	($143,361,711)	($2,285,925)	$2,543,529
BALANCE (in shares) at Mar. 31, 2015		0	157,187,658

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	($3,473,913)	($7,971,712)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	907,540	860,254
Provision for doubtful accounts	-49,984	133,726
Amortization of deferred financing costs	166,942	161,178
Change in fair value of warrant liability	0	5,392,594
Deferred income tax expense (benefit), net	288,178	-590,414
Loss from equity investment in non-consolidated affiliate	0	502,518
Effect of changes in foreign exchange	4,564	284,962
Stock-based compensation expense	787,710	393,914
Provision for obsolete inventories	281,000	200,000
Changes in operations, assets and liabilities:
Accounts receivable	-1,671,925	-1,959,593
Due from affiliates	-23,462	-193,680
Inventory	-7,223,601	-1,246,553
Prepaid expenses and supplies	77,587	-591,188
Other assets	-272,000	-188,867
Accounts payable and accrued expenses	1,321,722	-597,127
Accrued interest	0	6,379
Due to related parties	27,642	-416,064
Total adjustments	-5,378,087	2,152,039
NET CASH USED IN OPERATING ACTIVITIES	-8,852,000	-5,819,673
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	-333,742	-234,693
Acquisition of intangible assets	-160,109	-26,980
Change in restricted cash	-929	60,137
Payments under contingent consideration agreements	0	-5,940
NET CASH USED IN INVESTING ACTIVITIES	-494,780	-207,476
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from (payments on) Keltic facility	8,170,507	-4,548,284
Payments on Bourbon term loan	-1,270,100	-481,000
(Payments on) proceeds from Junior loan	-1,250,000	1,250,000
Proceeds from 5% Convertible notes	0	2,125,000
Net proceeds from (payments on) from foreign revolving credit facility	21,278	-73,797
Proceeds from issuance of common stock	3,319,915	4,531,643
Payments for costs of stock issuance	-186,347	-184,341
Proceeds from exercise of common stock warrants	598,715	3,848,332
Proceeds from exercise of common stock options	222,984	25,976
NET CASH PROVIDED BY FINANCING ACTIVITIES	9,626,952	6,493,529
EFFECTS OF FOREIGN CURRENCY TRANSLATION	2,930	2,798
NET INCREASE IN CASH AND CASH EQUIVALENTS	283,102	469,178
CASH AND CASH EQUIVALENTS - BEGINNING	908,501	439,323
CASH AND CASH EQUIVALENTS - ENDING	1,191,603	908,501
Schedule of non-cash investing and financing activities:
Conversion of series A preferred stock to common stock	0	8,349,539
Conversion of 5% convertible note, and accrued interest thereon, to common stock	451,417	0
Surrender of common stock in connection with exercise of common stock warrant	31,250	0
Interest paid	937,973	867,782
Income taxes paid	$293,525	$14,848

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows [Parenthetical] (Convertible Notes Payable [Member])	Mar. 31, 2015	Mar. 31, 2014
Convertible Notes Payable [Member]
Debt Instrument, Interest Rate, Stated Percentage	5.00%	5.00%

ORGANIZATION_AND_SUMMARY_OF_SI

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
		A.	Description of business — The consolidated financial statements include the accounts of Castle Brands Inc. (the “Company”), its wholly-owned domestic subsidiaries, Castle Brands (USA) Corp. (“CB-USA”) and McLain & Kyne, Ltd. (“McLain & Kyne”), the Company’s wholly-owned foreign subsidiaries, Castle Brands Spirits Group Limited (“CB-IRL”) and Castle Brands Spirits Marketing and Sales Company Limited, and the Company’s 60 % ownership interest in Gosling-Castle Partners Inc. (“GCP”), with adjustments for income or loss allocated based upon percentage of ownership. The accounts of the subsidiaries have been included as of the date of acquisition. All significant intercompany transactions and balances have been eliminated.
		B.	Organization and operations — The Company is principally engaged in the importation, marketing and sale of premium and super premium brands of rums, whiskey, liqueurs, vodka and tequila in the United States, Canada, Europe and Asia.
		C.	Brands — Rum and Ginger Beer — Gosling’s rums, a family of premium rums with a 200-year history, including the award-winning Gosling’s Black Seal rum, for which the Company is, through its export venture GCP, the exclusive marketer outside of Bermuda, and Gosling’s Stormy Ginger Beer, an essential non-alcoholic ingredient in Gosling’s trademarked Dark ‘n Stormy® rum cocktail.
			Whiskey —Premium small batch bourbons: Jefferson’s, Jefferson’s Reserve, Jefferson’s Chef’s Collaboration, Jefferson’s Ocean Aged at Sea and Jefferson’s Presidential Select, Jefferson’s Rye, an aged rye whiskey, and Jefferson’s The Manhattan: Barrel Finished Cocktail, a ready-to-drink cocktail; the Clontarf Irish whiskeys, a family of premium Irish whiskeys, available in single malt and classic pure grain versions; Knappogue Castle Whiskey, a vintage-dated premium single-malt Irish whiskey; Knappogue Castle 1951, a pure pot-still whiskey that has been aged for 36 years, and Knappogue Twin Wood, the first Sherry Finished Knappogue Castle Whiskey.
			Liqueur — Pallini Limoncello, Raspicello and Peachcello premium Italian liqueurs, pursuant to an exclusive U.S. marketing arrangement; Brady’s Irish Cream, a premium Irish cream liqueur; Castello Mio, a super premium Sambuca; Celtic Honey, a premium Irish liqueur; and Gozio amaretto, a premium Italian liqueur, pursuant to a U.S. distribution agreement.
			Vodka — Boru vodka, an ultra-pure, five-times distilled and specially filtered premium vodka. Boru is produced in Ireland.
			Tequila — a USDA certified organic, super-premium tequila, Tequila Tierras Autenticas de Jalisco or Tierras. The Company is the exclusive U.S. importer and marketer of Tierras, which is available as blanco, reposado and añejo.
		D.	Cash and cash equivalents — The Company considers all highly liquid instruments with a maturity at date of acquisition of three months or less to be cash equivalents.
		E.	Equity investments - Equity investments are carried at original cost adjusted for the Company’s proportionate share of the investees’ income, losses and distributions. The Company assesses the carrying value of its equity investments when an indicator of a loss in value is present and records a loss in value of the investment when the assessment indicates that an other-than-temporary decline in the investment exists. The Company classifies its equity earnings of non-consolidated affiliate equity investment as a component of net income or loss.
		F.	Trade accounts receivable — The Company records trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect anticipated losses on the trade accounts receivable balances. The Company calculates this allowance based on its history of write-offs, level of past due accounts based on contractual terms of the receivables and its relationships with and economic status of its customers. For the years ended March 31, 2015 and 2014, the Company recorded allowances for doubtful accounts of $236,000 and $403,409, respectively.
		G.	Revenue recognition — Revenue from product sales is recognized when the product is shipped to a customer (generally a distributor), title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination), and collection is reasonably assured. Revenue is not recognized on shipments to control states in the United States until such time as product is sold through to the retail channel.
		H.	Inventories — Inventories are comprised of distilled spirits, bulk wine, dry good raw materials (bottles, labels, corks and caps), packaging and finished goods, and are valued at the lower of cost or market, using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company’s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including, but not limited to, historical usage, expected future demand and market requirements. A change to the carrying value of inventories is recorded in cost of goods sold. See Note 3.
	During the years ended March 31, 2015 and 2014, the Company recorded allowances for obsolete and slow moving inventory of $281,000 and $200,000, respectively. The Company recorded these allowances on both raw materials and finished goods, primarily in connection with the disposition of wine brands, label and packaging changes made to certain brands, as well as wine spoilage and certain cost variances. The charges have been recorded as increases to Cost of Sales in the respective years.
		I.	Equipment — Equipment consists of office equipment, computers and software and furniture and fixtures. When assets are retired or otherwise disposed of, the cost and related depreciation is removed from the accounts, and any resulting gain or loss is recognized in the statement of operations. Equipment is depreciated using the straight-line method over the estimated useful lives of the assets ranging from three to five years.
		J.	Goodwill and other intangible assets — Goodwill represents the excess of purchase price including related costs over the value assigned to the net tangible and identifiable intangible assets of businesses acquired. Goodwill and other identifiable intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually, or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives, generally on a straight-line basis, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
			Under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, “Intangibles - Goodwill and Other”, impairment of goodwill must be tested at least annually by comparing the fair values of the applicable reporting units with the carrying amount of their net assets, including goodwill. The required two-step approach uses accounting judgments and estimates of future operating results. Changes in estimates or the application of alternative assumptions could produce significantly different results. The estimates that most significantly affect the fair value calculation are related to revenue growth, cost of sales, selling and marketing expenses and discount rates. Impairment testing is done at the reporting level. If the carrying amount of the reporting unit’s net assets exceeds the unit’s fair value, an impairment loss is recognized in an amount equal to the excess of the carrying amount of goodwill over its implied fair value. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination with the fair value of the reporting unit deemed to be the purchase price paid. Rights, trademarks, trade names and formulations are indefinite lived intangible assets not subject to amortization and are tested for impairment at least annually. The impairment test consists of a comparison of the fair value of the asset group allocated to each reporting unit with its allocated carrying amount.
			The fair value of each reporting unit was determined at March 31, 2015 and 2014 by weighting a combination of the present value of the Company’s discounted anticipated future operating cash flows and values based on market multiples of revenue and earnings before interest, taxes, depreciation and amortization (“EBITDA”) of comparable companies.
		K.	Impairment and disposal of long-lived assets — Under ASC 310, “Accounting for the Impairment or Disposal of Long-lived Assets”, the Company periodically reviews whether changes have occurred that would require revisions to the carrying amounts of its definite lived, long-lived assets. When the sum of the expected future cash flows is less than the carrying amount of the asset, an impairment loss is recognized based on the fair value of the asset. The Company did not record an impairment on long-lived assets for the years ended March 31, 2015 and 2014.
		L.	Shipping and handling — The Company reflects as inventory costs freight-in and related external handling charges relating to the purchase of raw materials and finished goods. These costs are charged to cost of sales at the time the underlying product is sold. The Company also incurs shipping costs in connection with its various marketing activities, including the shipment of point of sale materials to the Company’s regional sales managers and customers, and the costs of shipping product in connection with its various marketing programs and promotions. These shipping charges are included in selling expense and were $2,574,471 and $1,879,881 for the years ended March 31, 2015 and 2014, respectively.
		M.	Excise taxes and duty — Excise taxes and duty are computed at standard rates based on alcohol proof per gallon/liter and are paid after finished goods are imported into the United States and then transferred out of “bond.” Excise taxes and duty are recorded to inventory as a component of the cost of the underlying finished goods. When the underlying products are sold “ex warehouse”, the sales price reflects the taxes paid and the inventoried excise taxes and duties are charged to cost of sales.
		N.	Distributor charges and promotional goods — The Company incurs charges from its distributors for a variety of transactions and services rendered by the distributor, including product depletions, product samples for various promotional purposes, in-store tastings and training where legal, and local advertising where legal. Such charges are reflected as selling expense as incurred. Also, the Company has entered into arrangements with certain of its distributors whereby the purchase of a particular product or products by a distributor is accompanied by a percentage of the sale being composed of promotional goods or as a predetermined discount percentage of dollars off invoice. In such cases, the cost of the promotional goods is charged to cost of sales and dollars off invoice are a reduction to revenue.
		O.	Foreign currency — The functional currency for the Company’s foreign operations is the Euro in Ireland and the British Pound in the United Kingdom. Under ASC 830, “Foreign Currency Matters”, the translation from the applicable foreign currencies to U.S. Dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. The resulting translation adjustments are recorded as a component of other comprehensive income. Gains or losses resulting from foreign currency transactions are shown as a separate line item in the consolidated statements of operations.
		P.	Fair value of financial instruments — ASC 825, “Financial Instruments”, defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. The Company believes that there is no material difference between the fair-value and the reported amounts of financial instruments in the Company’s balance sheets due to the short term maturity of these instruments, or with respect to the Company’s debt, as compared to the current borrowing rates available to the Company.
			The Company’s investments are reported at fair value in accordance with authoritative guidance, which accomplishes the following key objectives:
		-	Defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date;
		-	Establishes a three-level hierarchy (“valuation hierarchy”) for fair value measurements;
		-	Requires consideration of the Company’s creditworthiness when valuing liabilities; and
		-	Expands disclosures about instruments measured at fair value.
			The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of the valuation hierarchy are as follows:
		-	Level 1 — inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
		-	Level 2 — inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are directly or indirectly observable for the asset or liability for substantially the full term of the financial instrument.
		-	Level 3 — inputs to the valuation methodology are unobservable and significant to the fair value measurement.
		Q.	Income taxes — Under ASC 740, “Income Taxes”, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided to the extent a deferred tax asset is not considered recoverable.
			The Company has adopted the provisions of ASC 740 and has recognized no adjustment for uncertain tax provisions. The Company recognizes interest and penalties related to uncertain tax positions in general and administrative expense.
		R.	Research and development costs — The costs of research, development and product improvement are charged to expense as incurred and are included in selling expense.
		S.	Advertising — Advertising costs are expensed when the advertising first appears in its respective medium. Advertising expense, which is included in selling expense, was $3,184,392 and $2,052,819 for the years ended March 31, 2015 and 2014, respectively.
		T.	Use of estimates — The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates include the accounting for items such as evaluating annual impairment tests, derivative instruments and equity issuances, warrant valuation, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, depreciation, amortization and expense accruals.
		U.	Recent accounting pronouncements — In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected. Upon adoption, the Company will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance. This guidance is effective for the Company beginning April 1, 2016. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In February 2015, the FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 amends the consolidation requirements and significantly changes the consolidation analysis required. ASU 2015-02 requires management to re-evaluate all legal entities under a revised consolidation model specifically (1) modify the evaluation of whether limited partnership and similar legal entities are Variable Interest Entities (“VIEs”), (2) eliminate the presumption that a general partner should consolidate a limited partnership, (3) affect the consolidation analysis of reporting entities that are involved with VIEs particularly those that have fee arrangements and related party relationships, and (4) provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Act of 1940 for registered money market funds. The guidance is effective for annual periods and interim periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this update provide that guidance. The amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term “substantial doubt,” (2) require an evaluation every reporting period, including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for annual periods ending after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718); Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in this ASU apply to all reporting entities that grant employees share-based payments in which the award terms provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period must be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. The amendments in this ASU are effective for annual periods and interim periods beginning after December 15, 2015. Earlier adoption is permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, to clarify the principles for recognizing revenue. This guidance includes the required steps to achieve the core principle that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for fiscal years and interim periods beginning after December 15, 2016. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			The Company does not believe that any other recently issued, but not yet effective accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.
		V.	Accounting standards adopted — In April 2014, the FASB issued ASU No. 2014-08 which provides final guidance to change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift, such as a major line of business, a major geographical area or a major equity investment, should be presented as discontinued operations. The guidance will be applied prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The Company adopted the guidance effective April 1, 2015 and the adoption of this guidance did not have a material impact on the Company’s results of operations, cash flows or financial condition.

BASIC_AND_DILUTED_NET_LOSS_PER

BASIC AND DILUTED NET LOSS PER COMMON SHARE	12 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 2 — BASIC AND DILUTED NET LOSS PER COMMON SHARE
	Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed giving effect to all potentially dilutive common shares that were outstanding during the period that are not anti-dilutive. Potentially dilutive common shares consist of incremental shares issuable upon exercise of stock options and warrants or conversion of convertible notes outstanding. In computing diluted net loss per share for the years ended March 31, 2015 and 2014, no adjustment has been made to the weighted average outstanding common shares as the assumed exercise of outstanding options and warrants and the assumed conversion of convertible notes is anti-dilutive.
	Potential common shares not included in calculating diluted net loss per share are as follows:
		Years ended March 31,
		2015		2014
	Stock options		11,988,188		11,174,007
	Warrants to purchase common stock		120,000		1,777,802
	5% Convertible notes		1,861,111		2,361,111
	Total		13,969,299		15,312,920

INVENTORIES

INVENTORIES	12 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE 3 — INVENTORIES
		March 31,
		2015		2014
	Raw materials – net	$	9,250,893	$	4,502,234
	Finished goods – net		11,817,348		10,147,795
	Total	$	21,068,241	$	14,650,029
	As of March 31, 2015 and 2014, 10% and 19%, respectively, of raw materials and 4% and 5%, respectively, of finished goods were located outside of the United States.
	In the years ended March 31, 2015 and 2014, the Company acquired $5,333,763 and $3,343,500 of aged bourbon whiskey, respectively, in support of its anticipated near and mid-term needs.
	The Company estimates the allowance for obsolete and slow moving inventory based on analyses and assumptions including, but not limited to, historical usage, expected future demand and market requirements.
	Inventories are stated at the lower of weighted average cost or market.

EQUITY_INVESTMENT

EQUITY INVESTMENT	12 Months Ended
	Mar. 31, 2015
Equity Method Investments and Joint Ventures [Abstract]
Cost and Equity Method Investments Disclosure [Text Block]	NOTE 4 — EQUITY INVESTMENT
	Investment in Gosling-Castle Partners Inc.
	As referenced in Note 11, GCP does not file consolidated tax returns with the Company. For the year ended March 31, 2015, GCP recognized $(288,178) of deferred tax expense on GCP’s estimated stand-alone taxable income. The Company allocated 40% of this expense, or ($115,271), to minority interest for the year ended March 31, 2015.
	Discontinuation of Investment in DP Castle Partners, LLC
	In August 2010, CB-USA formed DP Castle Partners, LLC (“DPCP”) with Drink Pie, LLC to manage the manufacturing and marketing of Travis Hasse’s Original Apple Pie Liqueur, Cherry Pie Liqueur and any future line extensions of the brand. In December 2013, CB-USA determined to cease marketing and selling these brands and returned the remaining inventory to Drink Pie, LLC. For the year ended March 31, 2014, CB-USA purchased $170,880 in finished goods from DPCP under a distribution agreement. At March 31, 2014, CB-USA owned 20% of now inactive DPCP. CB-USA also earned a defined rate of interest on its capital contribution to DPCP, based on its ownership in DPCP. For the year ended March 31, 2014, CB-USA earned $4,200 in interest income on its capital contribution to DPCP. The Company accounted for this investment under the equity method of accounting. In connection with the discontinuation of marketing and sales efforts, the Company recognized a loss of $502,518 from its investment in DPCP for the year ended March 31, 2014, including a $120,900 loss on investment and write-offs of $399,618 on the remaining receivable balances due from DPCP.

EQUIPMENT_NET

EQUIPMENT, NET	12 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 5 — EQUIPMENT, NET
	Equipment consists of the following:
		March 31,
		2015		2014
	Equipment and software	$	2,434,340	$	2,317,310
	Furniture and fixtures		40,898		10,325
			2,475,238		2,327,635
	Less: accumulated depreciation		1,809,865		1,759,240
	Balance	$	665,373	$	568,395
	Depreciation expense for the years ended March 31, 2015 and 2014 totaled $249,683 and $204,180, respectively.

GOODWILL_AND_INTANGIBLE_ASSETS

GOODWILL AND INTANGIBLE ASSETS	12 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	NOTE 6 — GOODWILL AND INTANGIBLE ASSETS
	The changes in the carrying amount of goodwill for the years ended March 31, 2015 and 2014 were as follows:
		Amount
	Balance as of March 31, 2013	$	490,286
	Payments under McLain and Kyne agreement		5,940
	Balance as of March 31, 2014	$	496,226
	Year ended March 31, 2015		—
	Balance as of March 31, 2015	$	496,226
	Intangible assets consist of the following:
		March 31,
		2015		2014
	Definite life brands	$	170,000	$	170,000
	Trademarks		631,693		535,947
	Rights		8,271,555		8,271,555
	Product development		161,321		96,959
	Patents		994,000		994,000
	Other		55,460		55,460
			10,284,029		10,123,921
	Less: accumulated amortization		6,713,774		6,058,005
	Net		3,570,255		4,065,916
	Other identifiable intangible assets — indefinite lived*		4,112,972		4,112,972
		$	7,683,227	$	8,178,888
	Accumulated amortization consists of the following:
		March 31,
		2015		2014
	Definite life brands	$	170,000	$	170,000
	Trademarks		295,956		262,098
	Rights		5,513,162		4,961,170
	Product development		24,002		20,350
	Patents		710,654		644,387
	Other		-		-
	Accumulated amortization	$	6,713,774	$	6,058,005
	* Other identifiable intangible assets — indefinite lived consists of product formulations and the Company’s relationships with its distillers.
	Amortization expense for the years ended March 31, 2015 and 2014 totaled $655,769 and $654,005, respectively.
	Estimated aggregate amortization expense for each of the next five fiscal years is as follows:
	Years ending March 31,	Amount
	2016	$	711,696
	2017		705,249
	2018		646,973
	2019		607,478
	2020		567,536
	Total	$	3,238,932

RESTRICTED_CASH

RESTRICTED CASH	12 Months Ended
	Mar. 31, 2015
Restricted Cash Disclosure [Abstract]
Restricted Cash Disclosure [Text Block]	NOTE 7 — RESTRICTED CASH
	At March 31, 2015 and 2014, the Company had €303,657 or $329,471 (translated at the March 31, 2015 exchange rate) and €302,920 or $416,565 (translated at the March 31, 2014 exchange rate), respectively, of cash restricted from withdrawal and held by a bank in Ireland as collateral for overdraft coverage, creditors’ insurance, customs and excise guaranty and a revolving credit facility as described in Note 8A below.

NOTES_PAYABLE_AND_CAPITAL_LEAS

NOTES PAYABLE AND CAPITAL LEASE	12 Months Ended
	Mar. 31, 2015
Long-Term Debt, Unclassified [Abstract]
Long-term Debt [Text Block]	NOTE 8 — NOTES PAYABLE AND CAPITAL LEASE
			March 31,
			2015		2014
	Notes payable consist of the following:
	Foreign revolving credit facilities (A)		$	34,141	$	20,205
	Note payable – GCP note (B)			211,580		211,580
	Keltic facility (C)			10,123,544		1,953,037
	Bourbon term loan (D)			744,900		2,015,000
	Junior loan (E)			—		1,250,000
	5% Convertible notes (F)			1,675,000		2,125,000
	Total		$	12,789,165	$	7,574,822
		A.	The Company has arranged various facilities aggregating €303,657 or $329,471 (translated at the March 31, 2015 exchange rate) with an Irish bank, including overdraft coverage, creditors’ insurance, customs and excise guaranty, and a revolving credit facility. These facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lender’s AA1 Rate minus 1.70%. The balance on the credit facilities included in notes payable totaled €31,466 or $34,141 (translated at the March 31, 2015 exchange rate) and €14,693 or $20,205 (translated at the March 31, 2014 exchange rate), at March 31, 2015 and 2014, respectively.
		B.	In December 2009, GCP issued a promissory note (the “GCP Note”) in the aggregate principal amount of $211,580 to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of 5%, to be accrued and paid at maturity. At March 31, 2015 and 2014, $10,579 of accrued interest was converted to amounts due to affiliates. At March 31, 2015 and 2014, $211,580 of principal due on the GCP Note was included in long-term liabilities.
		C.	In August 2011, the Company and CB-USA entered into a loan agreement with Keltic Financial Partners II, LP (“Keltic”), which, as amended, provides for availability (subject to certain terms and conditions) of a facility of up to $12.0 million (the “Keltic Facility”) for the purpose of providing the Company with working capital.
			In September 2014, the Company and CB-USA entered into an Amended and Restated Loan and Security Agreement (the “Amended Agreement”) with ACF FinCo I LP (“ACF”), as successor in interest to Keltic, in order to amend certain terms of the Keltic Facility and the Bourbon Term Loan (defined below). Among other changes, the Amended Agreement modified certain aspects of the existing Keltic Facility, including increasing the maximum amount of the Keltic Facility from $8,000,000 to $12,000,000 and increasing the inventory sub-limit from $4,000,000 to $6,000,000. In addition, the term of the Keltic Facility was extended from December 31, 2016 to July 31, 2019. The Keltic Facility interest rate was reduced to the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.25%. As of December 31, 2014, the Keltic Facility interest rate was 6.25%. The monthly facility fee was reduced from 1.00% per annum of the maximum Keltic Facility amount to 0.75%. In addition, the Amended Agreement contains EBITDA targets allowing for further interest rate reductions in the future. The Amended Agreement also modifies certain aspects of the EBITDA covenant that was contained in the previously existing loan and security agreement, dated as of August 19, 2011, as amended. The Company paid ACF an aggregate $120,000 amendment fee in connection with the execution of the Amended Agreement.
			In connection with the amendment, the Company and CB-USA entered into the following ancillary agreements: (i) a Reaffirmation Agreement with (a) certain officers of the Company and CB-USA, including John Glover, the Company’s Chief Operating Officer, T. Kelley Spillane, the Company’s Senior Vice President - Global Sales, and Alfred Small, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary, (b) certain participants in the Bourbon Term Loan and (c) certain junior lenders to the Company, including Frost Gamma Investments Trust, an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III, a director of the Company and the Company’s Chairman, an affiliate of Richard J. Lampen, a director of the Company and the Company’s President and Chief Executive Officer, an affiliate of Glenn Halpryn, a director of the Company, Dennis Scholl, a former director of the Company, and Vector Group Ltd., a more than 5% shareholder of the Company, of which Richard Lampen is an executive officer and Henry Beinstein, a director of the Company, is a director, which, among other things, reaffirms the existing Validity and Support Agreements by and among each officer, the Company, CB-USA and ACF, as successor-in-interest to Keltic; (ii) an Amended and Restated Term Note (the "Term Note"); and (iii) an Amended and Restated Revolving Credit Note (the "Revolving Note").
			In connection with the Amended Agreement, on September 22, 2014, ACF entered into an amendment to that certain Subordination Agreement, dated as of August 7, 2013 (as amended, the "Subordination Agreement"), by and among ACF, as successor-in-interest to Keltic, and certain junior lenders to the Company; neither the Company nor CB-USA is a party to the Subordination Agreement.
			The Company and CB-USA are referred to individually and collectively as the Borrower. The Borrower may borrow up to the maximum amount of the Keltic Facility, provided that the Borrower has a sufficient borrowing base (as defined under the Amended Agreement). For the year ended March 31, 2015, the Company paid interest at 6.5%, until such time as the interest was reduced to 6.25% in connection with the September 2014 amendment. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the Amended Agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Keltic Facility interest rate. There have been no Events of Default under the Keltic Facility. In addition to the fee in connection with the Amended Agreement, the Company paid a $40,000 commitment fee in connection with the first amendment, a $70,000 closing and commitment fee in connection with the second amendment and a $25,000 closing and commitment fee in connection with the third amendment. Keltic also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default). The Amended Agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The Amended Agreement includes negative covenants that, among other things, restrict the Borrower’s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. At March 31, 2015, the Company was in compliance, in all respects, with the covenants under the Amended Agreement. At March 31, 2015 and 2014, $10,123,544 and $1,953,037, respectively, due on the Keltic Facility was included in long-term liabilities.
		D.	In March 2013, the Company and CB-USA entered into an inventory term loan of $2,496,000 (the "Bourbon Term Loan") that was used to purchase bourbon inventory on March 11, 2013. Unless sooner terminated in accordance with its terms, the Bourbon Term Loan matures on July 31, 2019. The Bourbon Term Loan interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%. For the year ended March 31, 2015, the Company paid interest of 7.5%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the loan agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan, all accrued and unpaid interest thereon, and all fees, costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31, 2016.
	Keltic required as a condition to funding the Bourbon Term Loan that Keltic had entered into a participation agreement (the "Participation Agreement") providing for an initial aggregate amount of $750,000 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan, including Frost Gamma Investments Trust ($500,000), Mark E. Andrews, III ($50,000) and an affiliate of Richard J. Lampen ($50,000) (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement, the junior participants receive interest at the rate of 11% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However, the Borrower is party to a fee letter (the "Fee Letter") with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $45,000 in three equal annual installments of $15,000. In August 2013, the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $2,500,000 to up to $4,000,000 to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $744,900 and $2,015,000 at March 31, 2015 and 2014, respectively. In May 2015, the Bourbon Term Loan was paid in full in accordance with its standard terms in the normal course of business.
		E.	In August 2013, the Company entered into a Loan Agreement (the "Junior Loan Agreement"), by and between the Company and the lending parties thereto (the "Junior Lenders"), which provided for an aggregate $1,250,000 unsecured loan (the "Junior Loan") to the Company. The Junior Loan bore interest at a rate of 11% per annum, payable quarterly in arrears commencing November 1, 2013, and was set to mature on October 15, 2015. The Junior Loan Agreement provided for a funding fee of 2% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year), payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders included Frost Gamma Investments Trust ($200,000), Mark E. Andrews, III ($50,000) and an affiliate of Richard J. Lampen ($50,000)
			In September 2014, in connection with the Amended Agreement described in Note 8C, the Company used proceeds from the Keltic Facility to repay the $1,250,000 principal amount outstanding under the Junior Loan and all accrued and outstanding interest. At March 31, 2014, $1,250,000 of principal due on the Junior Loan was included in long-term liabilities.
		F.	In October 2013, the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the "Note Purchase Agreement") with the purchasers party thereto, under which the Company issued an aggregate initial principal amount of $2,125,000 of unsecured subordinated notes (the "Convertible Notes"). The Convertible Notes bear interest at a rate of 5% per annum, payable quarterly, until their maturity date of December 15, 2018. The Convertible Notes, and accrued but unpaid interest thereon, are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company’s common stock at a conversion price of $0.90 per share (the "Conversion Price"). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium, but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default, which, if uncured, entitle each note holder to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Convertible Notes.
			The purchasers of the Convertible Notes include related parties of the Company, including an affiliate of Dr. Phillip Frost ($500,000), Mark E. Andrews, III ($50,000), an affiliate of Richard J. Lampen ($50,000), an affiliate of Glenn Halpryn ($200,000), a director, Dennis Scholl ($100,000), a former director, and Vector Group Ltd. ($200,000).
			The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company’s common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50,000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any thirty (30) consecutive trading day period exceeds 250% of the then-current conversion price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder’s then-current note holdings.
			In connection with the Note Purchase Agreement, each purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement, by and among Keltic and certain other junior lenders to the Company; the Company is not a party to the Subordination Agreement.
			In the year ended March 31, 2015, Convertible Note holders converted $350,000 of Convertible Notes and $787 of accrued interest thereon into 389,676 shares of common stock. At March 31, 2015 and 2014, $1,675,000 and $2,125,000 of principal due on the Convertible Notes was included in long-term liabilities, respectively.
	Payments due on notes payable are as follows:
	Years ending March 31,		Amount
	2016		$	34,141
	2017			—
	2018			—
	2019			1,675,000
	2020			10,868,444
	Thereafter			211,580
	Total		$	12,789,165

EQUITY

EQUITY	12 Months Ended
	Mar. 31, 2015
Stockholders Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 9 — EQUITY
	Equity distribution agreement — In November 2014, the Company entered into an Equity Distribution Agreement (the "2014 Distribution Agreement") with Barrington Research Associates, Inc. ("Barrington"), as sales agent, under which the Company may issue and sell over time and from time to time, to or through Barrington, shares (the "Shares") of its common stock having a gross sales price of up to $10,000,000.
	Sales of the Shares pursuant to the 2014 Distribution Agreement, if any, may be effected by any method permitted by law deemed to be an "at-the-market" offering as defined in Rule 415 of the Securities Act of 1933, as amended, including without limitation directly on the NYSE MKT LLC or any other existing trading market for the common stock or through a market maker, up to the amount specified, and otherwise to or through Barrington in accordance with the placement notices delivered by the Company to Barrington. Also, with the prior consent of the Company, some of the Shares may be sold in privately negotiated transactions. Under the 2014 Distribution Agreement, Barrington will be entitled to compensation of 2.0 % of the gross proceeds from the sale of all of the Shares sold through Barrington, as sales agent, pursuant to the 2014 Distribution Agreement. Also, the Company will reimburse Barrington for certain expenses incurred in connection with the matters contemplated by the 2014 Distribution Agreement, up to an aggregate of $50,000, plus up to an additional $7,500 per calendar quarter related to ongoing maintenance; provided, however, that such reimbursement amount shall not exceed 8% of the aggregate gross proceeds received by the Company under the 2014 Distribution Agreement.
	From November 2014 through March 31, 2015, the Company sold 1,290,581 Shares pursuant to the 2014 Distribution Agreement, with total gross proceeds of $2,088,674, before deducting sales agent and offering expenses of $122,149.
	In November 2013, the Company entered into an Equity Distribution Agreement (the "2013 Distribution Agreement") with Barrington, as sales agent, under which the Company could issue and sell over time and from time to time, to or through Barrington, Shares of its common stock having a gross sales price of up to $6.0 million.
	In the three months ended June 30, 2014, the Company sold 1,247,343 Shares pursuant to the 2013 Distribution Agreement, with total gross proceeds of $1,231,241, before deducting sales agent and offering expenses of $64,198. No Shares were sold in the nine-month period from July 1, 2014 through March 31, 2015 under the 2013 Distribution Agreement.
	The 2013 Distribution Agreement expired in August 2014 upon the expiration of the Company’s Registration Statement on Form S-3 under which the shares were sold.
	Preferred stock dividends – Holders of the Company’s 10% Series A Convertible Preferred Stock, par value $0.01 per share (“Series A Preferred Stock”) were entitled to receive cumulative dividends at the rate per share (as a percentage of the stated value of $1,000 per share) of 10% per annum, whether or not declared by the Company’s Board of Directors, which were only payable in shares of the Company’s common stock upon conversion of the Series A Preferred Stock or upon a liquidation. For the year ended March 31, 2014, the Company recorded accrued dividends of $384,599, included as an increase in the accumulated deficit and in additional paid-in capital on the accompanying consolidated balance sheets.
	On February 11, 2014, the Company’s Board of Directors approved the mandatory conversion of all outstanding shares of the Series A Preferred Stock pursuant to their terms, effective on or about February 24, 2014. Pursuant to the mandatory conversion, all 6,271 outstanding shares of Series A Preferred Stock, and accrued dividends thereon, converted into 25,760,881 shares of common stock.
	Preferred stock conversions — In the period prior to the February 11, 2014 mandatory conversion, holders of Series A Preferred Stock converted 430 shares of Series A Preferred Stock, and accrued dividends thereon, into 1,704,729 shares of common stock.
	Convertible Notes conversion - In the year ended March 31, 2015, Convertible Note holders converted $350,000 of Convertible Notes and $787 of accrued interest thereon into 389,676 shares of common stock.

FOREIGN_CURRENCY_FORWARD_CONTR

FOREIGN CURRENCY FORWARD CONTRACTS	12 Months Ended
	Mar. 31, 2015
Foreign Currency [Abstract]
Foreign Currency Disclosure [Text Block]	NOTE 10 — FOREIGN CURRENCY FORWARD CONTRACTS
	The Company enters into forward contracts from time to time to reduce its exposure to foreign currency fluctuations. The Company recognizes in the balance sheet derivative contracts at fair value, and reflects any net gains and losses currently in earnings. At March 31, 2015 and 2014, the Company had no forward contracts outstanding. Gain or loss on foreign currency forward contracts, which was de minimis during the periods presented, is included in other income and expense.

PROVISION_FOR_INCOME_TAXES

PROVISION FOR INCOME TAXES	12 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 11 — PROVISION FOR INCOME TAXES
	The Company accounts for taxes in accordance with ASC 740, “Income Taxes”, which requires the recognition of tax benefits or expense on the temporary differences between the tax basis and book basis of its assets and liabilities. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those differences are expected to be recovered or settled.
	Tax years 2012 through 2015 remain open to examination by federal and state tax jurisdictions. The Company has various foreign subsidiaries for which tax years 2009 through 2015 remain open to examination in certain foreign tax jurisdictions.
	The Company’s income tax expense for the year ended March 31, 2015 and the Company’s income tax benefit for the year ended March 31, 2014 both consist of federal, state and local taxes attributable to GCP, which does not file a consolidated income tax return with the Company, and foreign taxes. As of March 31, 2015, the Company had federal net operating loss carryforwards of approximately $80,200,000 for U.S. tax purposes, which expire through 2035, and foreign net operating loss carryforwards of approximately $19,900,000, which carry forward without limit of time. Utilization of the U.S. tax losses may be limited by the “change of ownership” rules as set forth in section 382 of the Internal Revenue Code.
	The pre-tax income, on a financial statement basis, from foreign sources totaled $90,466 for the year ended March 31, 2015 and $168,233 for the year ended March 31, 2014.
	The Company did not have any undistributed earnings from foreign subsidiaries at March 31, 2015 and 2014.
	Income taxes consist of the following:
		Federal		State and Local		Total
	March 31, 2015:
	Current		608,589		382,232		990,821
	Deferred		214,958		73,220		288,178
	Total		823,547		455,452		1,278,999
	March 31, 2014:
	Current		—		31,068		31,068
	Deferred		-550,482		-71,000		-621,482
	Total		-550,482		-39,932		-590,414
	For the year ended March 31, 2015 the Company incurred $19,501 in interest and penalties which has been included in general and administrative expense on the accompanying consolidated statements of operations.
	The following table reconciles the effective income tax rate and the federal statutory rate of 34%.
		Years ended March 31,
		2015		2014
		%		%
	Computed expected tax benefit, at 34%		-34		-34
	Permanent items		3.1		0.8
	Change in valuation allowance		78.3		5.8
	Net change in fair value of warrant liability		0		25.2
	Effect of foreign rate differential		1.8		0.5
	Taxes included in minority interest		14.7		-0.3
	Intercompany profit		2.6		-0.5
	Other		3.5		3.1
	State and local taxes, net of federal benefit		-11.7		-7.46
	Income tax expense (benefit)		58.3		-6.86
	The Company revised its prior year presentation of the reconciliation of the effective income tax rate to conform to the current year presentation.
	In connection with the investment in GCP, the Company recorded a deferred tax liability on the ascribed value of the acquired intangible assets of $2,222,222, increasing the value of the asset. The deferred tax liability is being reversed over the amortization period of the intangible asset (15 years). For the year ended March 31, 2015 the Company recognized $1,278,999 of income tax expense, net and for the year ended March 31, 2014, the Company recognized $590,414 of income tax benefit, net.
	The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities are presented below.
		March 31,
		2015		2014
	Deferred income tax assets:
	Foreign currency transactions	$	74,000	$	72,000
	Accounts receivable		5,000		5,000
	Inventory		518,000		304,000
	Stock based compensation		2,440,000		2,125,000
	Amortization of intangibles		—		206,000
	Net operating loss carryforwards — U.S.		32,676,000		32,186,000
	Net operating loss carryforwards — foreign		1,990,000		1,974,000
	Other		2,000		2,000
	Total gross assets		37,705,000		36,874,000
	Less: Valuation allowance		-37,668,000		-36,401,000
	Net deferred asset	$	37,000	$	473,000
	Deferred income tax liability:
	Intangible assets acquired in acquisition of subsidiary	$	-629,444	$	-629,444
	Intangible assets acquired in investment in GCP		-740,708		-888,863
	Net deferred income tax liability	$	-1,370,152	$	-1,518,307
	In preparation of tax returns there was a true-up of March 31, 2014 net operating loss carryforwards - US by $2,520,000 that was offset by a change in the valuation allowance of $2,520,000.
	Through March 31, 2013, the Company recorded a full valuation allowance against its deferred tax assets as it believed it was more likely than not that such deferred tax assets would not be realized. The Company released its deferred tax asset valuation allowance allocated to GCP as of March 31, 2014 due to management’s determination that it was “more likely than not” that the GCP’s deferred tax assets would be realized. “More likely than not” is defined as greater than 50% probability of occurrence. Management considered the guidance in paragraphs 21-23 of ASC 740-10-30 in forming its conclusion. A determination as to the ultimate realization of the deferred tax assets is dependent upon management’s judgment and evaluation of both positive and negative evidence, forecasts of future taxable income, applicable tax planning strategies, and an assessment of current and future economic and business conditions. In 2014, GCP was in a position of cumulative profitability on a pre-tax basis, considering its operating results for the three years ended March 31, 2014. Management concluded that this record of cumulative profitability in recent years, in addition to a long range forecast showing continued profitability for GCP, provided sufficient positive evidence that the net U.S. federal tax benefits more likely than not would be realized. Accordingly, in the year ended March 31, 2014, the Company released the valuation allowance against GCP’s net federal deferred assets, resulting in a $473,330 benefit in provision for income taxes for the year ended March 31, 2014. The Company recognized the $473,330 benefit in provision for income taxes as an expense for the year ended March 31, 2015. In addition, at March 31, 2014, the Company changed its estimate of the cumulative deferred tax asset allocated to the amortization of intangibles. The Company’s income tax benefit and effective tax rate for the years ended March 31, 2015 and 2014 reflect the impact of this valuation allowance reversal and change in estimate.
	The valuation allowance for deferred tax assets as of March 31, 2015 and 2014 was approximately $37,668,000 and $36,401,000, respectively. The net change in the total valuation allowance for the years ended March 31, 2015 and 2014 was $1,267,000 and $258,000, respectively. The Company does not offset its deferred tax assets and liabilities because its deferred tax assets and liabilities are in different taxable entities which do not file consolidated returns.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 12 — STOCK-BASED COMPENSATION
		A.	Stock Incentive Plan — In July 2003, the Company implemented the 2003 Stock Incentive Plan (the “2003 Plan”), which provides for awards of incentive and non-qualified stock options, restricted stock and stock appreciation rights for its officers, employees, consultants and directors to attract and retain such individuals. Stock option grants under the Plan are granted with an exercise price at or above the fair market value of the underlying common stock at the date of grant, generally vest over a three to five year period and expire ten years after the grant date.
			As established, there were 2,000,000 shares of common stock available for distribution under the 2003 Plan. In January 2009, the Company’s shareholders approved an amendment to the 2003 Plan to increase the number of shares available under the 2003 Plan from 2,000,000 to 12,000,000 and to establish the maximum number of shares issuable to any one individual in any particular year. As of August 2013, no new awards may be issued under the 2003 Plan.
			In October 2012, the Company’s shareholders approved the 2013 Incentive Compensation Plan (“2013 Plan”) which provides for awards of incentive and non-qualified stock options, restricted stock and stock appreciation rights for its officers, employees, consultants and directors to attract and retain such individuals. As of March 31, 2015, 2,779,000 shares had been issued under the 2013 Plan, with 7,221,000 shares remaining available for issuance.
			Stock-based compensation expense for the years ended March 31, 2015 and 2014 amounted to $787,710 and $393,914, respectively, of which $178,137 and $81,567, respectively, is included in selling expense and $609,573 and $312,347, respectively, is included in general and administrative expense for the years ended March 31, 2015 and 2014, respectively. At March 31, 2015, total unrecognized compensation cost amounted to approximately $1,608,518, representing 4,924,055 unvested options. This cost is expected to be recognized over a weighted-average period of 2.22 years. There were 677,127 options and 80,758 options exercised during the years ended March 31, 2015 and 2014, respectively. The Company did not recognize any related tax benefit for the years ended March 31, 2015 and 2014, as the effects were de minimis.
			Stock Options — A summary of the options outstanding under the 2003 and 2013 Plans is as follows:
			Years ended March 31,
			2015						2014
						Weighted					Weighted
						Average					Average
						Exercise					Exercise
			Shares			Price			Shares		Price
	Outstanding at beginning of year			11,174,007		$	0.51			8,120,765	$	0.64
	Granted			2,525,000			1.04			3,300,000		0.43
	Exercised			-677,127			0.33			-80,758		0.32
	Forfeited			-1,033,692			1.1			-166,000		5.79
	Outstanding and expected to vest at end of period			11,988,188		$	0.58			11,174,007	$	0.51
	Exercisable at period end			7,064,133		$	0.49			5,511,447	$	0.63
	Weighted average fair value of grants during the period					$	0.65				$	0.26
	The following table summarizes activity pertaining to options outstanding and exercisable at March 31, 2015:
			Options Outstanding						Options Exercisable
						Weighted
						Average					Weighted
						Remaining					Average		Aggregate
	Range of					Life in					Exercise		Intrinsic
	Exercise Prices		Shares			Years			Shares		Price		Value
	$0.01 — $0.25			580,300			3.6			580,300	$	0.22	$	682,957
	$0.26 — $0.40			8,532,888			6.28			6,076,833		0.34		6,470,305
	$1.01 — $2.00			2,741,000			9.05			273,000		1.26		69,870
	$6.01 — $7.00			17,000			1.99			17,000		6.36		—
	$7.01 — $8.00			109,500			1.21			109,500		7.57		—
	$8.01 — $9.00			7,500			1.86			7,500		9		—
				11,988,188			6.73			7,064,133	$	0.49	$	7,223,132
	Total stock options exercisable as of March 31, 2015 were 7,064,133. The weighted average exercise price of these options was $0.49. The weighted average remaining life of the options outstanding was 6.73 years and of the options exercisable was 5.56 years.
	The following summarizes activity pertaining to the Company’s unvested options for the years ended March 31, 2015 and 2014:
						Weighted
						Average
						Exercise
			Shares			Price
	Unvested at March 31, 2013			3,871,807		$	0.32
	Granted			3,300,000			0.43
	Canceled or expired			-10,000			0.32
	Vested			-1,499,247			0.32
	Unvested at March 31, 2014			5,662,560		$	0.32
	Granted			2,525,000			1.04
	Canceled or expired			-954,083			0.44
	Vested			-2,309,422			0.41
	Unvested at March 31, 2015			4,924,055		$	0.7
	The fair value of each award under the 2003 and 2013 Plans is estimated on the grant date using the Black-Scholes option pricing model and is affected by assumptions regarding a number of complex and subjective variables. The use of an option pricing model also requires the use of a number of complex assumptions including expected volatility, risk-free interest rate, expected dividends, and expected term. Expected volatility is based on the Company’s historical volatility and the volatility of a peer group of companies over the expected life of the option. The expected term and vesting of the options represents the estimated period of time until exercise. The expected term was determined using the simplified method available under current guidance. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The Company has not paid dividends on its common stock in the past and does not plan to pay any dividends on its common stock in the near future. Current authoritative guidance also requires the Company to estimate forfeitures at the time of grant and revise these estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company estimates forfeitures based on its expectation of future experience while considering its historical experience.
	The fair value of options at grant date was estimated using the Black-Scholes option pricing model utilizing the following weighted average assumptions:
			March 31,
			2015			2014
	Risk-free interest rate			1.47% - 1.76	%		0.86% - 1.85	%
	Expected option life in years			5.5 - 6.25			5.5 - 6.25
	Expected stock price volatility			74% - 77	%		65% - 76	%
	Expected dividend yield			0	%		0	%
		B.	Warrants — The Company has entered into various warrant agreements.
	2011 Warrants issued in connection with the Series A Preferred Stock
	The warrants issued in connection with the Series A Preferred Stock (the “2011 Warrants”) had an exercise price of $0.38 per share, subject to adjustment, and were exercisable for a period of five years. The exercise price of the 2011 Warrants was equal to 125% of the conversion price of the Series A Preferred Stock.
	The Company accounted for the 2011 Warrants issued in June 2011 in the consolidated financial statements as a liability at their initial fair value of $487,022 and accounted for the 2011 Warrants issued in October 2011 as a liability at their initial fair value of $780,972. Changes in the fair value of the 2011 Warrants were recognized in earnings for each subsequent reporting period. In November 2013, in accordance with certain terms of the 2011 Warrants, the down-round provisions included in the terms of the warrant ceased to be in force or effect as a result of the historical volume weighted average price and trading volume of the Company’s common stock. The Company then reclassed the fair value of the outstanding warrant liability of $6,187,968 to equity, resulting in an increase to additional paid-in capital.
	For the year ended March 31, 2014 the Company recorded a loss on the change in the value of the 2011 Warrants of $5,392,594.
	The fair value of the warrants is a Level 3 fair value under the valuation hierarchy and was estimated using the Black-Scholes option pricing model utilizing the following assumptions:
			At Conversion
	Stock price		$	0.92
Risk-free interest rate			0.61	%
Expected option life in years			2.63
Expected stock price volatility			55	%
Expected dividend yield			0	%
2011 Warrants exercised – On April 2, 2014, the Company called for the cancellation of all 1,657,802 unexercised 2011 Warrants pursuant to the terms of such 2011 Warrants after satisfying applicable conditions. Pursuant to the call for cancellation, holders of all 1,657,802 unexercised 2011 Warrants exercised such 2011 Warrants and received 1,657,802 shares of common stock. The Company received $629,965 in cash upon the exercise of these warrants. In the year ended March 31, 2014, holders of 2011 Warrants exercised 10,127,123 2011 Warrants and received shares of common stock. The Company received $3,848,332 in cash upon the exercise of these warrants. These exercised warrants had a weighted average fair market value of $0.50 at exercise date.
For the year ended March 31, 2014, 1,543,214 warrant shares expired unexercised with a weighted average fair market value of $0.00.
The following is a summary of the Company’s outstanding warrants for the periods presented:
					Weighted
					Average
					Exercise
					Price
		Warrants			Per Warrant
Warrants outstanding and exercisable, March 31, 2013			11,904,925		$	0.46
Granted			—			—
Exercised			-10,127,123			0.38
Forfeited			—			—
Warrants outstanding and exercisable, March 31, 2014			1,777,802		$	0.9
Granted			—			—
Exercised			—			—
Forfeited			-1,657,802			0.38
Warrants outstanding and exercisable, March 31, 2015			120,000		$	8

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 13 — RELATED PARTY TRANSACTIONS
		A.	Pallini S.p.A. (“Pallini”), as successor in interest to I.L.A.R. S.p.A., is a shareholder in the Company and one of the officers of Pallini served as a director of the Company until March 26, 2015. In January 2011, CB-USA entered into an agreement ("New Agreement") with Pallini regarding the importation and distribution of certain Pallini brand products. The terms of the New Agreement were effective as of April 1, 2010.
			Under the New Agreement, the Company is permitted to import Pallini Limoncello and its flavor extensions at a set price, updated annually, and is obligated to set aside a portion of the gross margin toward a marketing fund for Pallini. The New Agreement also encompasses the hiring of a Pallini Brand Manager at the Company with Pallini reimbursing the costs of this position up to a stipulated annual amount. These reimbursements are included in selling expense.
			For the years ended March 31, 2015 and 2014, the Company purchased goods from Pallini for $3,840,446 and $3,467,812, respectively. As of March 31, 2015 and 2014, Pallini owed the Company $138,750 and $115,288, respectively, for its share of marketing expense, which is included in due from shareholders and affiliates on the consolidated balance sheet. As of March 31, 2015 and 2014, the Company was indebted to Pallini for $511,146 and $229,557, respectively, which is included in due to shareholders and affiliates on the consolidated balance sheet.
		B.	In November 2008, the Company entered into a management services agreement with Vector Group Ltd., a more than 5% shareholder, under which Vector Group agreed to make available to the Company the services of Richard J. Lampen, Vector Group’s executive vice president, effective October 11, 2008 to serve as the Company’s president and chief executive officer and to provide certain other financial and accounting services, including assistance with complying with Section 404 of the Sarbanes-Oxley Act of 2002. In consideration for such services, the Company agreed to pay Vector Group an annual fee of $100,000, plus any direct, out-of-pocket costs, fees and other expenses incurred by Vector Group or Mr. Lampen in connection with providing such services, and to indemnify Vector Group for any liabilities arising out of the provision of the services. The agreement is terminable by either party upon 30 days’ prior written notice. For the years ended March 31, 2015 and 2014, Vector Group was paid $135,475 and $104,746, respectively, under this agreement. These charges have been included in general and administrative expense.
		C.	In November 2008, the Company entered into an agreement to reimburse Ladenburg Thalmann Financial Services Inc. (“LTS”) for its costs in providing certain administrative, legal and financial services to the Company. For the years ended March 31, 2015 and 2014, LTS was paid $210,875 and $126,000, respectively, under this agreement. Mr. Lampen, the Company’s president and chief executive officer and a director, is the president and chief executive officer and a director of LTS and four other directors of the Company serve as directors of LTS, including Phillip Frost, M.D. who is the Chairman and principal shareholder of LTS.
		D.	As described in Note 8D, in March 2013, the Company entered into a Participation Agreement with certain related parties. As described in Notes 8E and 8F, in August and October 2013, the Company entered into various notes with certain related parties.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 14 — COMMITMENTS AND CONTINGENCIES
		A.	The Company has entered into a supply agreement with Irish Distillers Limited (“IDL”), which provides for the production of blended Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. IDL may terminate the contract if it provides at least six years prior notice to the Company, except for breach. Under this agreement, the Company provides IDL with a forecast of the estimated amount of liters of pure alcohol it requires for the next four fiscal contract years and agrees to purchase 90% of that amount, subject to certain annual adjustments. For the contract year ending June 30, 2015, the Company has contracted to purchase approximately €774,662 or $840,516 (translated at the March 31, 2015 exchange rate) in bulk Irish whiskey, of which €729,533, or $791,551, has been purchased as of March 31, 2015. For the contract year ending June 30, 2016, the Company has contracted to purchase approximately €833,673 or $904,544 (translated at the March 31, 2015 exchange rate) in bulk Irish whiskey. The Company is not obligated to pay IDL for any product not yet received. During the term of this supply agreement, IDL has the right to limit additional purchases above the commitment amount.
		B.	The Company has also entered into a supply agreement with IDL, which provides for the production of single malt Irish whiskeys for the Company until the contract is terminated by either party in accordance with the terms of the agreement. IDL may terminate the contract if it provides at least thirteen years prior notice to the Company, except for breach. Under this agreement, the Company provides IDL with a forecast of the estimated amount of liters of pure alcohol it requires for the next twelve fiscal contract years and agrees to purchase 80% of that amount, subject to certain annual adjustments. For the contract year ending June 30, 2015, the Company has contracted to purchase approximately €303,998 or $329,841 (translated at the March 31, 2015 exchange rate) in bulk Irish whiskey, of which €217,865, or $236,386, has been purchased as of March 31, 2015. For the year ending June 30, 2016, the Company has contracted to purchase approximately €343,787 or $373,012 (translated at the March 31, 2015 exchange rate) in bulk Irish whiskey. The Company is not obligated to pay IDL for any product not yet received. During the term of this supply agreement, IDL has the right to limit additional purchases above the commitment amount.
		C.	The Company has a distribution agreement with Gaelic Heritage Corporation, Ltd., an international supplier, to be the sole-producer of Celtic Honey, one of the Company’s products, for an indefinite period.
		D.	The Company leases office space in New York, NY, Dublin, Ireland and Houston, TX. The New York, NY lease began on May 1, 2010 and expires on April 30, 2016 and provides for monthly payments of $19,975. The Dublin lease commenced on March 1, 2009 and extends through October 31, 2016 and provides for monthly payments of €1,100 or $1,194 (translated at the March 31, 2015 exchange rate). The Houston, TX lease commenced on April 27, 2015 and extends through June 26, 2018 and provides for monthly payments of $3,440. The Company has also entered into non-cancelable operating leases for certain office equipment.
	Future minimum lease payments for leases with initial or remaining terms in excess of one year are as follows:
	Years ending March 31,		Amount
	2016		$	289,379
	2017			70,012
	2018			42,546
	2019			10,742
	Total		$	412,679
			In addition to the above annual rental payments, the Company is obligated to pay its pro-rata share of utility and maintenance expenses on the leased premises. Rent expense under operating leases amounted to approximately $359,714 and $356,280 for the years ended March 31, 2015 and 2014, respectively, and is included in general and administrative expense.
		D.	Under the amended terms of the agreement under which the Company purchased McLain & Kyne, the Company was obligated to pay an earn-out to the sellers based on the financial performance of the acquired business. As of June 30, 2013, the Company had reached the specified case sale threshold for contingent consideration under the agreement. Accordingly, no further contingent consideration will be due. For the years ended March 31, 2015 and 2014, the sellers earned $0 and $5,940, respectively, under this agreement.
		E.	As described in Note 8C, in August 2011, the Company and CB-USA entered into the Keltic Facility, as amended in July 2012, March 2013, August 2013, November 2013, August 2014 and September 2014.
		F.	Except as set forth below, the Company believes that neither it nor any of its subsidiaries is currently subject to litigation which, in the opinion of management after consultation with counsel, is likely to have a material adverse effect on the Company.
			The Company may become involved in litigation from time to time relating to claims arising in the ordinary course of its business. These claims, even if not meritorious, could result in the expenditure of significant financial and managerial resources.

CONCENTRATIONS

CONCENTRATIONS	12 Months Ended
	Mar. 31, 2015
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	NOTE 15 — CONCENTRATIONS
		A.	Credit Risk — The Company maintains its cash and cash equivalents balances at various large financial institutions that, at times, may exceed federally and internationally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk or cash.
		B.	Customers — Sales to one customer, the Southern Wine and Spirits of America, Inc. family of companies, accounted for approximately 29.7% and 31.9% of the Company’s net sales for the years ended March 31, 2015 and 2014, respectively, and approximately 30.1% and 35.1% of accounts receivable at March 31, 2015 and 2014, respectively.

GEOGRAPHIC_INFORMATION

GEOGRAPHIC INFORMATION	12 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	NOTE 16 — GEOGRAPHIC INFORMATION
	The Company operates in one reportable segment — the sale of premium beverage alcohol. The Company’s product categories are rum and related products, liqueur, whiskey, vodka and tequila. The Company reports its operations in two geographic areas: International and United States.
	The consolidated financial statements include revenues and assets generated in or held in the U.S. and foreign countries. The following table sets forth the amounts and percentage of consolidated sales, net, consolidated income (loss) from operations, consolidated net loss attributable to controlling interests, consolidated income tax (expense) benefit and consolidated assets from the U.S. and foreign countries and consolidated sales, net by category.
		Years ended March 31,
		2015				2014
	Consolidated Sales, net:
	International	$	7,938,393	13.8	%	$	7,305,516	15.2	%
	United States		49,519,028	86.2	%		40,834,967	84.8	%
	Total Consolidated Sales, net	$	57,457,421	100	%	$	48,140,483	100	%
	Consolidated Income (Loss) from Operations:
	International	$	17,172	-1.6	%	$	-266	0	%
	United States		-1,095,077	101.6	%		-1,319,567	100	%
	Total Consolidated Loss from Operations	$	-1,077,905	100	%	$	-1,319,833	100	%
	Consolidated Net Loss Attributable to Controlling Interests:
	International	$	-101,453	2.7	%	$	-153,419	1.7	%
	United States		-3,698,289	97.3	%		-8,753,328	98.3	%
	Total Consolidated Net Loss Attributable to Controlling Interests	$	-3,799,742	100	%	$	-8,906,747	100	%
	Income tax (expense) benefit, net:
	United States	$	-1,278,999	100	%	$	590,414	100	%
	Consolidated Sales, net by category:
	Rum	$	16,998,034	29.6	%	$	16,643,640	34.6	%
	Whiskey		19,147,028	33.3	%		13,521,875	28.1	%
	Liqueurs		8,756,376	15.2	%		8,992,277	18.7	%
	Vodka		2,413,994	4.2	%		2,852,956	5.9	%
	Tequila		208,845	0.4	%		218,552	0.5	%
	Wine		—	0	%		284,806	0.6	%
	Related Non-Alcoholic Beverage Products		9,933,144	17.3	%		5,626,377	11.6	%
	Total Consolidated Sales, net	$	57,457,421	100	%	$	48,140,483	100	%
		As of March 31,
		2015				2014
	Consolidated Assets:
	International	$	2,052,583	4.7	%	$	2,201,343	6	%
	United States		41,986,357	95.3	%		34,320,167	94	%
	Total Consolidated Assets	$	44,038,940	100	%	$	36,521,510	100	%

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 17 — SUBSEQUENT EVENTS
	Equity distribution agreement - Between April 1, 2015 and June 11, 2015, the Company sold an additional  633,209 Shares pursuant to the 2014 Distribution Agreement, with total gross proceeds of $1,040,541, before deducting sales agent and offering expenses of $20,870.
	Investment in Copperhead Distillery Company
	In June 2015, the Company purchased approximately 20% of Copperhead Distillery Company (“Copperhead”) for $500,000. Copperhead owns and operates the Kentucky Artisan Distillery. The investment is part of a wide-reaching agreement to build a new warehouse to store Jefferson’s bourbons, provide distilling capabilities using special mash-bills made from locally grown grains, and create a visitor center and store to enhance the consumer experience for the Jefferson’s brand. The Company’s investment will be used for the construction of a new warehouse in Crestwood, Kentucky dedicated exclusively to Jefferson’s and will be accounted for under the equity method of accounting.

ORGANIZATION_AND_SUMMARY_OF_SI1

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]		A.	Description of business — The consolidated financial statements include the accounts of Castle Brands Inc. (the “Company”), its wholly-owned domestic subsidiaries, Castle Brands (USA) Corp. (“CB-USA”) and McLain & Kyne, Ltd. (“McLain & Kyne”), the Company’s wholly-owned foreign subsidiaries, Castle Brands Spirits Group Limited (“CB-IRL”) and Castle Brands Spirits Marketing and Sales Company Limited, and the Company’s 60 % ownership interest in Gosling-Castle Partners Inc. (“GCP”), with adjustments for income or loss allocated based upon percentage of ownership. The accounts of the subsidiaries have been included as of the date of acquisition. All significant intercompany transactions and balances have been eliminated.
Organization and Operation [Policy Text Block]		B.	Organization and operations — The Company is principally engaged in the importation, marketing and sale of premium and super premium brands of rums, whiskey, liqueurs, vodka and tequila in the United States, Canada, Europe and Asia.
Brands [Policy Text Block]		C.	Brands — Rum and Ginger Beer — Gosling’s rums, a family of premium rums with a 200-year history, including the award-winning Gosling’s Black Seal rum, for which the Company is, through its export venture GCP, the exclusive marketer outside of Bermuda, and Gosling’s Stormy Ginger Beer, an essential non-alcoholic ingredient in Gosling’s trademarked Dark ‘n Stormy® rum cocktail.
			Whiskey —Premium small batch bourbons: Jefferson’s, Jefferson’s Reserve, Jefferson’s Chef’s Collaboration, Jefferson’s Ocean Aged at Sea and Jefferson’s Presidential Select, Jefferson’s Rye, an aged rye whiskey, and Jefferson’s The Manhattan: Barrel Finished Cocktail, a ready-to-drink cocktail; the Clontarf Irish whiskeys, a family of premium Irish whiskeys, available in single malt and classic pure grain versions; Knappogue Castle Whiskey, a vintage-dated premium single-malt Irish whiskey; Knappogue Castle 1951, a pure pot-still whiskey that has been aged for 36 years, and Knappogue Twin Wood, the first Sherry Finished Knappogue Castle Whiskey.
			Liqueur — Pallini Limoncello, Raspicello and Peachcello premium Italian liqueurs, pursuant to an exclusive U.S. marketing arrangement; Brady’s Irish Cream, a premium Irish cream liqueur; Castello Mio, a super premium Sambuca; Celtic Honey, a premium Irish liqueur; and Gozio amaretto, a premium Italian liqueur, pursuant to a U.S. distribution agreement.
			Vodka — Boru vodka, an ultra-pure, five-times distilled and specially filtered premium vodka. Boru is produced in Ireland.
			Tequila — a USDA certified organic, super-premium tequila, Tequila Tierras Autenticas de Jalisco or Tierras. The Company is the exclusive U.S. importer and marketer of Tierras, which is available as blanco, reposado and añejo.
Cash and Cash Equivalents, Policy [Policy Text Block]		D.	Cash and cash equivalents — The Company considers all highly liquid instruments with a maturity at date of acquisition of three months or less to be cash equivalents.
Equity Method Investments, Policy [Policy Text Block]		E.	Equity investments - Equity investments are carried at original cost adjusted for the Company’s proportionate share of the investees’ income, losses and distributions. The Company assesses the carrying value of its equity investments when an indicator of a loss in value is present and records a loss in value of the investment when the assessment indicates that an other-than-temporary decline in the investment exists. The Company classifies its equity earnings of non-consolidated affiliate equity investment as a component of net income or loss.
Trade and Other Accounts Receivable, Policy [Policy Text Block]		F.	Trade accounts receivable — The Company records trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect anticipated losses on the trade accounts receivable balances. The Company calculates this allowance based on its history of write-offs, level of past due accounts based on contractual terms of the receivables and its relationships with and economic status of its customers. For the years ended March 31, 2015 and 2014, the Company recorded allowances for doubtful accounts of $236,000 and $403,409, respectively.
Revenue Recognition, Policy [Policy Text Block]		G.	Revenue recognition — Revenue from product sales is recognized when the product is shipped to a customer (generally a distributor), title and risk of loss has passed to the customer in accordance with the terms of sale (FOB shipping point or FOB destination), and collection is reasonably assured. Revenue is not recognized on shipments to control states in the United States until such time as product is sold through to the retail channel.
Inventory, Policy [Policy Text Block]		H.	Inventories — Inventories are comprised of distilled spirits, bulk wine, dry good raw materials (bottles, labels, corks and caps), packaging and finished goods, and are valued at the lower of cost or market, using the weighted average cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company’s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analyses and assumptions including, but not limited to, historical usage, expected future demand and market requirements. A change to the carrying value of inventories is recorded in cost of goods sold. See Note 3.
	During the years ended March 31, 2015 and 2014, the Company recorded allowances for obsolete and slow moving inventory of $281,000 and $200,000, respectively. The Company recorded these allowances on both raw materials and finished goods, primarily in connection with the disposition of wine brands, label and packaging changes made to certain brands, as well as wine spoilage and certain cost variances. The charges have been recorded as increases to Cost of Sales in the respective years.
Property, Plant and Equipment, Policy [Policy Text Block]		I.	Equipment — Equipment consists of office equipment, computers and software and furniture and fixtures. When assets are retired or otherwise disposed of, the cost and related depreciation is removed from the accounts, and any resulting gain or loss is recognized in the statement of operations. Equipment is depreciated using the straight-line method over the estimated useful lives of the assets ranging from three to five years.
Goodwill and Intangible Assets, Policy [Policy Text Block]		J.	Goodwill and other intangible assets — Goodwill represents the excess of purchase price including related costs over the value assigned to the net tangible and identifiable intangible assets of businesses acquired. Goodwill and other identifiable intangible assets with indefinite lives are not amortized, but instead are tested for impairment annually, or more frequently if circumstances indicate a possible impairment may exist. Intangible assets with estimable useful lives are amortized over their respective estimated useful lives, generally on a straight-line basis, and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable.
			Under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, “Intangibles - Goodwill and Other”, impairment of goodwill must be tested at least annually by comparing the fair values of the applicable reporting units with the carrying amount of their net assets, including goodwill. The required two-step approach uses accounting judgments and estimates of future operating results. Changes in estimates or the application of alternative assumptions could produce significantly different results. The estimates that most significantly affect the fair value calculation are related to revenue growth, cost of sales, selling and marketing expenses and discount rates. Impairment testing is done at the reporting level. If the carrying amount of the reporting unit’s net assets exceeds the unit’s fair value, an impairment loss is recognized in an amount equal to the excess of the carrying amount of goodwill over its implied fair value. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination with the fair value of the reporting unit deemed to be the purchase price paid. Rights, trademarks, trade names and formulations are indefinite lived intangible assets not subject to amortization and are tested for impairment at least annually. The impairment test consists of a comparison of the fair value of the asset group allocated to each reporting unit with its allocated carrying amount.
			The fair value of each reporting unit was determined at March 31, 2015 and 2014 by weighting a combination of the present value of the Company’s discounted anticipated future operating cash flows and values based on market multiples of revenue and earnings before interest, taxes, depreciation and amortization (“EBITDA”) of comparable companies.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]		K.	Impairment and disposal of long-lived assets — Under ASC 310, “Accounting for the Impairment or Disposal of Long-lived Assets”, the Company periodically reviews whether changes have occurred that would require revisions to the carrying amounts of its definite lived, long-lived assets. When the sum of the expected future cash flows is less than the carrying amount of the asset, an impairment loss is recognized based on the fair value of the asset. The Company did not record an impairment on long-lived assets for the years ended March 31, 2015 and 2014.
Shipping and Handling Cost, Policy [Policy Text Block]		L.	Shipping and handling — The Company reflects as inventory costs freight-in and related external handling charges relating to the purchase of raw materials and finished goods. These costs are charged to cost of sales at the time the underlying product is sold. The Company also incurs shipping costs in connection with its various marketing activities, including the shipment of point of sale materials to the Company’s regional sales managers and customers, and the costs of shipping product in connection with its various marketing programs and promotions. These shipping charges are included in selling expense and were $2,574,471 and $1,879,881 for the years ended March 31, 2015 and 2014, respectively.
Excise Taxes and Duty [Policy Text Block]		M.	Excise taxes and duty — Excise taxes and duty are computed at standard rates based on alcohol proof per gallon/liter and are paid after finished goods are imported into the United States and then transferred out of “bond.” Excise taxes and duty are recorded to inventory as a component of the cost of the underlying finished goods. When the underlying products are sold “ex warehouse”, the sales price reflects the taxes paid and the inventoried excise taxes and duties are charged to cost of sales.
Distributor Charges And Promotional Goods [Policy Text Block]		N.	Distributor charges and promotional goods — The Company incurs charges from its distributors for a variety of transactions and services rendered by the distributor, including product depletions, product samples for various promotional purposes, in-store tastings and training where legal, and local advertising where legal. Such charges are reflected as selling expense as incurred. Also, the Company has entered into arrangements with certain of its distributors whereby the purchase of a particular product or products by a distributor is accompanied by a percentage of the sale being composed of promotional goods or as a predetermined discount percentage of dollars off invoice. In such cases, the cost of the promotional goods is charged to cost of sales and dollars off invoice are a reduction to revenue.
Foreign Currency Transactions and Translations Policy [Policy Text Block]		O.	Foreign currency — The functional currency for the Company’s foreign operations is the Euro in Ireland and the British Pound in the United Kingdom. Under ASC 830, “Foreign Currency Matters”, the translation from the applicable foreign currencies to U.S. Dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet date and for revenue and expense accounts using a weighted average exchange rate during the period. The resulting translation adjustments are recorded as a component of other comprehensive income. Gains or losses resulting from foreign currency transactions are shown as a separate line item in the consolidated statements of operations.
Fair Value Of Financial Instruments, Policy [Policy Text Block]		P.	Fair value of financial instruments — ASC 825, “Financial Instruments”, defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties and requires disclosure of the fair value of certain financial instruments. The Company believes that there is no material difference between the fair-value and the reported amounts of financial instruments in the Company’s balance sheets due to the short term maturity of these instruments, or with respect to the Company’s debt, as compared to the current borrowing rates available to the Company.
			The Company’s investments are reported at fair value in accordance with authoritative guidance, which accomplishes the following key objectives:
		-	Defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date;
		-	Establishes a three-level hierarchy (“valuation hierarchy”) for fair value measurements;
		-	Requires consideration of the Company’s creditworthiness when valuing liabilities; and
		-	Expands disclosures about instruments measured at fair value.
			The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of the valuation hierarchy are as follows:
		-	Level 1 — inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
		-	Level 2 — inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are directly or indirectly observable for the asset or liability for substantially the full term of the financial instrument.
		-	Level 3 — inputs to the valuation methodology are unobservable and significant to the fair value measurement.
Income Tax, Policy [Policy Text Block]		Q.	Income taxes — Under ASC 740, “Income Taxes”, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided to the extent a deferred tax asset is not considered recoverable.
			The Company has adopted the provisions of ASC 740 and has recognized no adjustment for uncertain tax provisions. The Company recognizes interest and penalties related to uncertain tax positions in general and administrative expense.
Research and Development Expense, Policy [Policy Text Block]		R.	Research and development costs — The costs of research, development and product improvement are charged to expense as incurred and are included in selling expense.
Advertising Costs, Policy [Policy Text Block]		S.	Advertising — Advertising costs are expensed when the advertising first appears in its respective medium. Advertising expense, which is included in selling expense, was $3,184,392 and $2,052,819 for the years ended March 31, 2015 and 2014, respectively.
Use of Estimates, Policy [Policy Text Block]		T.	Use of estimates — The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates include the accounting for items such as evaluating annual impairment tests, derivative instruments and equity issuances, warrant valuation, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, depreciation, amortization and expense accruals.
New Accounting Pronouncements, Policy [Policy Text Block]		U.	Recent accounting pronouncements — In April 2015, the FASB issued ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected. Upon adoption, the Company will apply the new guidance on a retrospective basis and adjust the balance sheet of each individual period presented to reflect the period-specific effects of applying the new guidance. This guidance is effective for the Company beginning April 1, 2016. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In February 2015, the FASB issued ASU 2015-02, Consolidation: Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 amends the consolidation requirements and significantly changes the consolidation analysis required. ASU 2015-02 requires management to re-evaluate all legal entities under a revised consolidation model specifically (1) modify the evaluation of whether limited partnership and similar legal entities are Variable Interest Entities (“VIEs”), (2) eliminate the presumption that a general partner should consolidate a limited partnership, (3) affect the consolidation analysis of reporting entities that are involved with VIEs particularly those that have fee arrangements and related party relationships, and (4) provide a scope exception from consolidation guidance for reporting entities with interests in legal entities that are required to comply with or operate in accordance with requirements that are similar to those in Rule 2a-7 of the Investment Act of 1940 for registered money market funds. The guidance is effective for annual periods and interim periods beginning after December 15, 2015. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this update provide that guidance. The amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term “substantial doubt,” (2) require an evaluation every reporting period, including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this update are effective for annual periods ending after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718); Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period. The amendments in this ASU apply to all reporting entities that grant employees share-based payments in which the award terms provide that a performance target that affects vesting could be achieved after the requisite service period. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period must be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. The amendments in this ASU are effective for annual periods and interim periods beginning after December 15, 2015. Earlier adoption is permitted. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, to clarify the principles for recognizing revenue. This guidance includes the required steps to achieve the core principle that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for fiscal years and interim periods beginning after December 15, 2016. The Company is currently evaluating the new guidance to determine the impact the adoption of this guidance will have on the Company’s results of operations, cash flows and financial condition.
			The Company does not believe that any other recently issued, but not yet effective accounting standards, if currently adopted, would have a material effect on the accompanying financial statements.
Accounting Standards Adopted Policy [Policy Text Block]		V.	Accounting standards adopted — In April 2014, the FASB issued ASU No. 2014-08 which provides final guidance to change the criteria for reporting discontinued operations while enhancing disclosures in this area. Under the new guidance, only disposals representing a strategic shift, such as a major line of business, a major geographical area or a major equity investment, should be presented as discontinued operations. The guidance will be applied prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The Company adopted the guidance effective April 1, 2015 and the adoption of this guidance did not have a material impact on the Company’s results of operations, cash flows or financial condition.

BASIC_AND_DILUTED_NET_LOSS_PER1

BASIC AND DILUTED NET LOSS PER COMMON SHARE (Tables)	12 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Potential common shares not included in calculating diluted net loss per share are as follows:
		Years ended March 31,
		2015		2014
	Stock options		11,988,188		11,174,007
	Warrants to purchase common stock		120,000		1,777,802
	5% Convertible notes		1,861,111		2,361,111
	Total		13,969,299		15,312,920

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]		March 31,
		2015		2014
	Raw materials – net	$	9,250,893	$	4,502,234
	Finished goods – net		11,817,348		10,147,795
	Total	$	21,068,241	$	14,650,029

EQUIPMENT_NET_Tables

EQUIPMENT, NET (Tables)	12 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Equipment consists of the following:
		March 31,
		2015		2014
	Equipment and software	$	2,434,340	$	2,317,310
	Furniture and fixtures		40,898		10,325
			2,475,238		2,327,635
	Less: accumulated depreciation		1,809,865		1,759,240
	Balance	$	665,373	$	568,395

GOODWILL_AND_INTANGIBLE_ASSETS1

GOODWILL AND INTANGIBLE ASSETS (Tables)	12 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	The changes in the carrying amount of goodwill for the years ended March 31, 2015 and 2014 were as follows:
		Amount
	Balance as of March 31, 2013	$	490,286
	Payments under McLain and Kyne agreement		5,940
	Balance as of March 31, 2014	$	496,226
	Year ended March 31, 2015		—
	Balance as of March 31, 2015	$	496,226
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Intangible assets consist of the following:
		March 31,
		2015		2014
	Definite life brands	$	170,000	$	170,000
	Trademarks		631,693		535,947
	Rights		8,271,555		8,271,555
	Product development		161,321		96,959
	Patents		994,000		994,000
	Other		55,460		55,460
			10,284,029		10,123,921
	Less: accumulated amortization		6,713,774		6,058,005
	Net		3,570,255		4,065,916
	Other identifiable intangible assets — indefinite lived*		4,112,972		4,112,972
		$	7,683,227	$	8,178,888
	* Other identifiable intangible assets — indefinite lived consists of product formulations and the Company’s relationships with its distillers.
Accumulated Amortization [Table Text Block]	Accumulated amortization consists of the following:
		March 31,
		2015		2014
	Definite life brands	$	170,000	$	170,000
	Trademarks		295,956		262,098
	Rights		5,513,162		4,961,170
	Product development		24,002		20,350
	Patents		710,654		644,387
	Other		-		-
	Accumulated amortization	$	6,713,774	$	6,058,005
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Estimated aggregate amortization expense for each of the next five fiscal years is as follows:
	Years ending March 31,	Amount
	2016	$	711,696
	2017		705,249
	2018		646,973
	2019		607,478
	2020		567,536
	Total	$	3,238,932

NOTES_PAYABLE_AND_CAPITAL_LEAS1

NOTES PAYABLE AND CAPITAL LEASE (Tables)	12 Months Ended
	Mar. 31, 2015
Long-Term Debt, Unclassified [Abstract]
Schedule Of Notes Payable and Credit Facility [Table Text Block]			March 31,
			2015		2014
	Notes payable consist of the following:
	Foreign revolving credit facilities (A)		$	34,141	$	20,205
	Note payable – GCP note (B)			211,580		211,580
	Keltic facility (C)			10,123,544		1,953,037
	Bourbon term loan (D)			744,900		2,015,000
	Junior loan (E)			—		1,250,000
	5% Convertible notes (F)			1,675,000		2,125,000
	Total		$	12,789,165	$	7,574,822
		A.	The Company has arranged various facilities aggregating €303,657 or $329,471 (translated at the March 31, 2015 exchange rate) with an Irish bank, including overdraft coverage, creditors’ insurance, customs and excise guaranty, and a revolving credit facility. These facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lender’s AA1 Rate minus 1.70%. The balance on the credit facilities included in notes payable totaled €31,466 or $34,141 (translated at the March 31, 2015 exchange rate) and €14,693 or $20,205 (translated at the March 31, 2014 exchange rate), at March 31, 2015 and 2014, respectively.
		B.	In December 2009, GCP issued a promissory note (the “GCP Note”) in the aggregate principal amount of $211,580 to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of 5%, to be accrued and paid at maturity. At March 31, 2015 and 2014, $10,579 of accrued interest was converted to amounts due to affiliates. At March 31, 2015 and 2014, $211,580 of principal due on the GCP Note was included in long-term liabilities.
		C.	In August 2011, the Company and CB-USA entered into a loan agreement with Keltic Financial Partners II, LP (“Keltic”), which, as amended, provides for availability (subject to certain terms and conditions) of a facility of up to $12.0 million (the “Keltic Facility”) for the purpose of providing the Company with working capital.
			In September 2014, the Company and CB-USA entered into an Amended and Restated Loan and Security Agreement (the “Amended Agreement”) with ACF FinCo I LP (“ACF”), as successor in interest to Keltic, in order to amend certain terms of the Keltic Facility and the Bourbon Term Loan (defined below). Among other changes, the Amended Agreement modified certain aspects of the existing Keltic Facility, including increasing the maximum amount of the Keltic Facility from $8,000,000 to $12,000,000 and increasing the inventory sub-limit from $4,000,000 to $6,000,000. In addition, the term of the Keltic Facility was extended from December 31, 2016 to July 31, 2019. The Keltic Facility interest rate was reduced to the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.25%. As of December 31, 2014, the Keltic Facility interest rate was 6.25%. The monthly facility fee was reduced from 1.00% per annum of the maximum Keltic Facility amount to 0.75%. In addition, the Amended Agreement contains EBITDA targets allowing for further interest rate reductions in the future. The Amended Agreement also modifies certain aspects of the EBITDA covenant that was contained in the previously existing loan and security agreement, dated as of August 19, 2011, as amended. The Company paid ACF an aggregate $120,000 amendment fee in connection with the execution of the Amended Agreement.
			In connection with the amendment, the Company and CB-USA entered into the following ancillary agreements: (i) a Reaffirmation Agreement with (a) certain officers of the Company and CB-USA, including John Glover, the Company’s Chief Operating Officer, T. Kelley Spillane, the Company’s Senior Vice President - Global Sales, and Alfred Small, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary, (b) certain participants in the Bourbon Term Loan and (c) certain junior lenders to the Company, including Frost Gamma Investments Trust, an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III, a director of the Company and the Company’s Chairman, an affiliate of Richard J. Lampen, a director of the Company and the Company’s President and Chief Executive Officer, an affiliate of Glenn Halpryn, a director of the Company, Dennis Scholl, a former director of the Company, and Vector Group Ltd., a more than 5% shareholder of the Company, of which Richard Lampen is an executive officer and Henry Beinstein, a director of the Company, is a director, which, among other things, reaffirms the existing Validity and Support Agreements by and among each officer, the Company, CB-USA and ACF, as successor-in-interest to Keltic; (ii) an Amended and Restated Term Note (the "Term Note"); and (iii) an Amended and Restated Revolving Credit Note (the "Revolving Note").
			In connection with the Amended Agreement, on September 22, 2014, ACF entered into an amendment to that certain Subordination Agreement, dated as of August 7, 2013 (as amended, the "Subordination Agreement"), by and among ACF, as successor-in-interest to Keltic, and certain junior lenders to the Company; neither the Company nor CB-USA is a party to the Subordination Agreement.
			The Company and CB-USA are referred to individually and collectively as the Borrower. The Borrower may borrow up to the maximum amount of the Keltic Facility, provided that the Borrower has a sufficient borrowing base (as defined under the Amended Agreement). For the year ended March 31, 2015, the Company paid interest at 6.5%, until such time as the interest was reduced to 6.25% in connection with the September 2014 amendment. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the Amended Agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Keltic Facility interest rate. There have been no Events of Default under the Keltic Facility. In addition to the fee in connection with the Amended Agreement, the Company paid a $40,000 commitment fee in connection with the first amendment, a $70,000 closing and commitment fee in connection with the second amendment and a $25,000 closing and commitment fee in connection with the third amendment. Keltic also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default). The Amended Agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The Amended Agreement includes negative covenants that, among other things, restrict the Borrower’s ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. At March 31, 2015, the Company was in compliance, in all respects, with the covenants under the Amended Agreement. At March 31, 2015 and 2014, $10,123,544 and $1,953,037, respectively, due on the Keltic Facility was included in long-term liabilities.
		D.	In March 2013, the Company and CB-USA entered into an inventory term loan of $2,496,000 (the "Bourbon Term Loan") that was used to purchase bourbon inventory on March 11, 2013. Unless sooner terminated in accordance with its terms, the Bourbon Term Loan matures on July 31, 2019. The Bourbon Term Loan interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%. For the year ended March 31, 2015, the Company paid interest of 7.5%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the loan agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan, all accrued and unpaid interest thereon, and all fees, costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31, 2016.
	Keltic required as a condition to funding the Bourbon Term Loan that Keltic had entered into a participation agreement (the "Participation Agreement") providing for an initial aggregate amount of $750,000 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan, including Frost Gamma Investments Trust ($500,000), Mark E. Andrews, III ($50,000) and an affiliate of Richard J. Lampen ($50,000) (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement, the junior participants receive interest at the rate of 11% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However, the Borrower is party to a fee letter (the "Fee Letter") with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $45,000 in three equal annual installments of $15,000. In August 2013, the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $2,500,000 to up to $4,000,000 to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $744,900 and $2,015,000 at March 31, 2015 and 2014, respectively. In May 2015, the Bourbon Term Loan was paid in full in accordance with its standard terms in the normal course of business.
		E.	In August 2013, the Company entered into a Loan Agreement (the "Junior Loan Agreement"), by and between the Company and the lending parties thereto (the "Junior Lenders"), which provided for an aggregate $1,250,000 unsecured loan (the "Junior Loan") to the Company. The Junior Loan bore interest at a rate of 11% per annum, payable quarterly in arrears commencing November 1, 2013, and was set to mature on October 15, 2015. The Junior Loan Agreement provided for a funding fee of 2% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year), payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders included Frost Gamma Investments Trust ($200,000), Mark E. Andrews, III ($50,000) and an affiliate of Richard J. Lampen ($50,000)
			In September 2014, in connection with the Amended Agreement described in Note 8C, the Company used proceeds from the Keltic Facility to repay the $1,250,000 principal amount outstanding under the Junior Loan and all accrued and outstanding interest. At March 31, 2014, $1,250,000 of principal due on the Junior Loan was included in long-term liabilities.
		F.	In October 2013, the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the "Note Purchase Agreement") with the purchasers party thereto, under which the Company issued an aggregate initial principal amount of $2,125,000 of unsecured subordinated notes (the "Convertible Notes"). The Convertible Notes bear interest at a rate of 5% per annum, payable quarterly, until their maturity date of December 15, 2018. The Convertible Notes, and accrued but unpaid interest thereon, are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Company’s common stock at a conversion price of $0.90 per share (the "Conversion Price"). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium, but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default, which, if uncured, entitle each note holder to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Convertible Notes.
			The purchasers of the Convertible Notes include related parties of the Company, including an affiliate of Dr. Phillip Frost ($500,000), Mark E. Andrews, III ($50,000), an affiliate of Richard J. Lampen ($50,000), an affiliate of Glenn Halpryn ($200,000), a director, Dennis Scholl ($100,000), a former director, and Vector Group Ltd. ($200,000).
			The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Company’s common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50,000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any thirty (30) consecutive trading day period exceeds 250% of the then-current conversion price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holder’s then-current note holdings.
			In connection with the Note Purchase Agreement, each purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement, by and among Keltic and certain other junior lenders to the Company; the Company is not a party to the Subordination Agreement.
			In the year ended March 31, 2015, Convertible Note holders converted $350,000 of Convertible Notes and $787 of accrued interest thereon into 389,676 shares of common stock. At March 31, 2015 and 2014, $1,675,000 and $2,125,000 of principal due on the Convertible Notes was included in long-term liabilities, respectively.
Schedule of Maturities of Long-term Debt [Table Text Block]	Payments due on notes payable are as follows:
	Years ending March 31,		Amount
	2016		$	34,141
	2017			—
	2018			—
	2019			1,675,000
	2020			10,868,444
	Thereafter			211,580
	Total		$	12,789,165

PROVISION_FOR_INCOME_TAXES_Tab

PROVISION FOR INCOME TAXES (Tables)	12 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	Income taxes consist of the following:
		Federal		State and Local		Total
	March 31, 2015:
	Current		608,589		382,232		990,821
	Deferred		214,958		73,220		288,178
	Total		823,547		455,452		1,278,999
	March 31, 2014:
	Current		—		31,068		31,068
	Deferred		-550,482		-71,000		-621,482
	Total		-550,482		-39,932		-590,414
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The following table reconciles the effective income tax rate and the federal statutory rate of 34%.
		Years ended March 31,
		2015		2014
		%		%
	Computed expected tax benefit, at 34%		-34		-34
	Permanent items		3.1		0.8
	Change in valuation allowance		78.3		5.8
	Net change in fair value of warrant liability		0		25.2
	Effect of foreign rate differential		1.8		0.5
	Taxes included in minority interest		14.7		-0.3
	Intercompany profit		2.6		-0.5
	Other		3.5		3.1
	State and local taxes, net of federal benefit		-11.7		-7.46
	Income tax expense (benefit)		58.3		-6.86
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities are presented below.
		March 31,
		2015		2014
	Deferred income tax assets:
	Foreign currency transactions	$	74,000	$	72,000
	Accounts receivable		5,000		5,000
	Inventory		518,000		304,000
	Stock based compensation		2,440,000		2,125,000
	Amortization of intangibles		—		206,000
	Net operating loss carryforwards — U.S.		32,676,000		32,186,000
	Net operating loss carryforwards — foreign		1,990,000		1,974,000
	Other		2,000		2,000
	Total gross assets		37,705,000		36,874,000
	Less: Valuation allowance		-37,668,000		-36,401,000
	Net deferred asset	$	37,000	$	473,000
	Deferred income tax liability:
	Intangible assets acquired in acquisition of subsidiary	$	-629,444	$	-629,444
	Intangible assets acquired in investment in GCP		-740,708		-888,863
	Net deferred income tax liability	$	-1,370,152	$	-1,518,307

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Mar. 31, 2015
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	The following table summarizes activity pertaining to options outstanding and exercisable at March 31, 2015:
		Options Outstanding						Options Exercisable
					Weighted
					Average					Weighted
					Remaining					Average		Aggregate
	Range of				Life in					Exercise		Intrinsic
	Exercise Prices	Shares			Years			Shares		Price		Value
	$0.01 — $0.25		580,300			3.6			580,300	$	0.22	$	682,957
	$0.26 — $0.40		8,532,888			6.28			6,076,833		0.34		6,470,305
	$1.01 — $2.00		2,741,000			9.05			273,000		1.26		69,870
	$6.01 — $7.00		17,000			1.99			17,000		6.36		—
	$7.01 — $8.00		109,500			1.21			109,500		7.57		—
	$8.01 — $9.00		7,500			1.86			7,500		9		—
			11,988,188			6.73			7,064,133	$	0.49	$	7,223,132
Schedule of Nonvested Share Activity [Table Text Block]	The following summarizes activity pertaining to the Company’s unvested options for the years ended March 31, 2015 and 2014:
					Weighted
					Average
					Exercise
		Shares			Price
	Unvested at March 31, 2013		3,871,807		$	0.32
	Granted		3,300,000			0.43
	Canceled or expired		-10,000			0.32
	Vested		-1,499,247			0.32
	Unvested at March 31, 2014		5,662,560		$	0.32
	Granted		2,525,000			1.04
	Canceled or expired		-954,083			0.44
	Vested		-2,309,422			0.41
	Unvested at March 31, 2015		4,924,055		$	0.7
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The fair value of options at grant date was estimated using the Black-Scholes option pricing model utilizing the following weighted average assumptions:
		March 31,
		2015			2014
	Risk-free interest rate		1.47% - 1.76	%		0.86% - 1.85	%
	Expected option life in years		5.5 - 6.25			5.5 - 6.25
	Expected stock price volatility		74% - 77	%		65% - 76	%
	Expected dividend yield		0	%		0	%
Warrants Liabilities [Table Text Block]	The fair value of the warrants is a Level 3 fair value under the valuation hierarchy and was estimated using the Black-Scholes option pricing model utilizing the following assumptions:
		At Conversion
	Stock price	$	0.92
	Risk-free interest rate		0.61	%
	Expected option life in years		2.63
	Expected stock price volatility		55	%
	Expected dividend yield		0	%
Warrant [Member]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following is a summary of the Company’s outstanding warrants for the periods presented:
					Weighted
					Average
					Exercise
					Price
		Warrants			Per Warrant
	Warrants outstanding and exercisable, March 31, 2013		11,904,925		$	0.46
	Granted		—			—
	Exercised		-10,127,123			0.38
	Forfeited		—			—
	Warrants outstanding and exercisable, March 31, 2014		1,777,802		$	0.9
	Granted		—			—
	Exercised		—			—
	Forfeited		-1,657,802			0.38
	Warrants outstanding and exercisable, March 31, 2015		120,000		$	8
Stock Option [Member]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Stock Options — A summary of the options outstanding under the 2003 and 2013 Plans is as follows:
		Years ended March 31,
		2015						2014
					Weighted					Weighted
					Average					Average
					Exercise					Exercise
		Shares			Price			Shares		Price
	Outstanding at beginning of year		11,174,007		$	0.51			8,120,765	$	0.64
	Granted		2,525,000			1.04			3,300,000		0.43
	Exercised		-677,127			0.33			-80,758		0.32
	Forfeited		-1,033,692			1.1			-166,000		5.79
	Outstanding and expected to vest at end of period		11,988,188		$	0.58			11,174,007	$	0.51
	Exercisable at period end		7,064,133		$	0.49			5,511,447	$	0.63
	Weighted average fair value of grants during the period				$	0.65				$	0.26

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Future minimum lease payments for leases with initial or remaining terms in excess of one year are as follows:
	Years ending March 31,	Amount
	2016	$	289,379
	2017		70,012
	2018		42,546
	2019		10,742
	Total	$	412,679

GEOGRAPHIC_INFORMATION_Tables

GEOGRAPHIC INFORMATION (Tables)	12 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	The following table sets forth the amounts and percentage of consolidated sales, net, consolidated income (loss) from operations, consolidated net loss attributable to controlling interests, consolidated income tax (expense) benefit and consolidated assets from the U.S. and foreign countries and consolidated sales, net by category.
		Years ended March 31,
		2015				2014
	Consolidated Sales, net:
	International	$	7,938,393	13.8	%	$	7,305,516	15.2	%
	United States		49,519,028	86.2	%		40,834,967	84.8	%
	Total Consolidated Sales, net	$	57,457,421	100	%	$	48,140,483	100	%
	Consolidated Income (Loss) from Operations:
	International	$	17,172	-1.6	%	$	-266	0	%
	United States		-1,095,077	101.6	%		-1,319,567	100	%
	Total Consolidated Loss from Operations	$	-1,077,905	100	%	$	-1,319,833	100	%
	Consolidated Net Loss Attributable to Controlling Interests:
	International	$	-101,453	2.7	%	$	-153,419	1.7	%
	United States		-3,698,289	97.3	%		-8,753,328	98.3	%
	Total Consolidated Net Loss Attributable to Controlling Interests	$	-3,799,742	100	%	$	-8,906,747	100	%
	Income tax (expense) benefit, net:
	United States	$	-1,278,999	100	%	$	590,414	100	%
	Consolidated Sales, net by category:
	Rum	$	16,998,034	29.6	%	$	16,643,640	34.6	%
	Whiskey		19,147,028	33.3	%		13,521,875	28.1	%
	Liqueurs		8,756,376	15.2	%		8,992,277	18.7	%
	Vodka		2,413,994	4.2	%		2,852,956	5.9	%
	Tequila		208,845	0.4	%		218,552	0.5	%
	Wine		—	0	%		284,806	0.6	%
	Related Non-Alcoholic Beverage Products		9,933,144	17.3	%		5,626,377	11.6	%
	Total Consolidated Sales, net	$	57,457,421	100	%	$	48,140,483	100	%
		As of March 31,
		2015				2014
	Consolidated Assets:
	International	$	2,052,583	4.7	%	$	2,201,343	6	%
	United States		41,986,357	95.3	%		34,320,167	94	%
	Total Consolidated Assets	$	44,038,940	100	%	$	36,521,510	100	%

ORGANIZATION_AND_SUMMARY_OF_SI2

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Summary Of Significant Accounting Policies [Line Items]
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	60.00%
Reversal Of Provision For Obsolete Inventory	$281,000	$200,000
Property, Plant and Equipment, Depreciation Methods	straight-line method
Property, Plant and Equipment, Estimated Useful Lives	three to five years
Shipping, Handling and Transportation Costs	2,574,471	1,879,881
Advertising Expense	3,184,392	2,052,819
Allowance for Doubtful Accounts Receivable	$236,000	$403,409

BASIC_AND_DILUTED_NET_LOSS_PER2

BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares not included in calculating diluted net loss per share	13,969,299	15,312,920
Stock options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares not included in calculating diluted net loss per share	11,988,188	11,174,007
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares not included in calculating diluted net loss per share	120,000	1,777,802
5% Convertible notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common shares not included in calculating diluted net loss per share	1,861,111	2,361,111

BASIC_AND_DILUTED_NET_LOSS_PER3

BASIC AND DILUTED NET LOSS PER COMMON SHARE (Details Textual) (Convertible Notes Payable [Member])	Mar. 31, 2015	Mar. 31, 2014
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	5.00%	5.00%

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Inventory [Line Items]
Raw materials - net	$9,250,893	$4,502,234
Finished goods - net	11,817,348	10,147,795
Total	$21,068,241	$14,650,029

INVENTORIES_Details_Textual

INVENTORIES (Details Textual) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Inventory [Line Items]
Percentage Of Raw Materials Located Outside United States	10.00%	19.00%
Percentage Of Finished Goods Located Outside United States	4.00%	5.00%
Payments To Acquire Inventory	$5,333,763	$3,343,500

EQUITY_INVESTMENT_Details_Text

EQUITY INVESTMENT (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Schedule of Equity Method Investments [Line Items]
Deferred Income Tax Expense (Benefit)	$288,178	($590,414)
Income (Loss) From Equity Method Investments	0	-502,518
Gosling-Castle Partners, Inc [Member]
Schedule of Equity Method Investments [Line Items]
Deferred Income Tax Expense (Benefit)	-288,178
Gosling-Castle Partners, Inc [Member] | Noncontrolling Interest [Member]
Schedule of Equity Method Investments [Line Items]
Deferred Income Tax Expense (Benefit)	115,271
Deferred Income Tax Expense Benefit, Minority Interest Percentage	40.00%
DPCP [Member]
Schedule of Equity Method Investments [Line Items]
Payment To Acquire Finished Goods		170,880
Equity Method Investment, Ownership Percentage		20.00%
Interest On Capital Contribution		4,200
Income (Loss) From Equity Method Investments		502,518
Equity Method Investment, Realized Gain (Loss) on Disposal		120,900
Equity Method Investment Write Off On Discontinuation Of Operations		$399,618

ACQUISITIONS_Details_Textual

ACQUISITIONS (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Business Acquisition [Line Items]
Payments under McLain & Kyne agreement	$0	$5,940

EQUIPMENT_NET_Details

EQUIPMENT, NET (Details) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Property, Plant and Equipment [Line Items]
Equipment and software	$2,434,340	$2,317,310
Furniture and fixtures	40,898	10,325
Property, Plant and Equipment, Gross	2,475,238	2,327,635
Less: accumulated depreciation	1,809,865	1,759,240
Balance	$665,373	$568,395

EQUIPMENT_NET_Details_Textual

EQUIPMENT, NET (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Property, Plant and Equipment [Line Items]
Depreciation	$249,683	$204,180

GOODWILL_AND_INTANGIBLE_ASSETS2

GOODWILL AND INTANGIBLE ASSETS (Details) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Goodwill [Line Items]
Balance	$496,226	$490,286
Payments under McLain and Kyne agreement	0	5,940
Balance	$496,226	$496,226

GOODWILL_AND_INTANGIBLE_ASSETS3

GOODWILL AND INTANGIBLE ASSETS (Details 1) (USD $)	Mar. 31, 2015		Mar. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Definite life brands	$170,000		$170,000
Trademarks	631,693		535,947
Rights	8,271,555		8,271,555
Product development	161,321		96,959
Patents	994,000		994,000
Other	55,460		55,460
Finite-Lived Intangible Assets, Gross	10,284,029		10,123,921
Less: accumulated amortization	6,713,774		6,058,005
Net	3,570,255		4,065,916
Other identifiable intangible assets - indefinite lived	4,112,972	[1]	4,112,972	[1]
Total intangible assets, net	$7,683,227		$8,178,888
[1]	Other identifiable intangible assets B indefinite lived consists of product formulations and the Companybs relationships with its distillers.

GOODWILL_AND_INTANGIBLE_ASSETS4

GOODWILL AND INTANGIBLE ASSETS (Details 2) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	$6,713,774	$6,058,005
Definite Life Brands [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	170,000	170,000
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	295,956	262,098
Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	5,513,162	4,961,170
Product Development [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	24,002	20,350
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	710,654	644,387
Other Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated amortization	$0	$0

GOODWILL_AND_INTANGIBLE_ASSETS5

GOODWILL AND INTANGIBLE ASSETS (Details 3) (USD $)	Mar. 31, 2015
Goodwill [Line Items]
2016	$711,696
2017	705,249
2018	646,973
2019	607,478
2020	567,536
Total	$3,238,932

GOODWILL_AND_INTANGIBLE_ASSETS6

GOODWILL AND INTANGIBLE ASSETS (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets	$655,769	$654,005

RESTRICTED_CASH_Details_Textua

RESTRICTED CASH (Details Textual)	Mar. 31, 2015	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2014
	USD ($)	EUR (€)	USD ($)	EUR (€)
Restricted Cash and Cash Equivalents Items [Line Items]
Restricted Cash and Cash Equivalents, Noncurrent	$329,471	€ 303,657	$416,565	€ 302,920

NOTES_PAYABLE_AND_CAPITAL_LEAS2

NOTES PAYABLE AND CAPITAL LEASE (Details) (USD $)	Mar. 31, 2015		Mar. 31, 2014
Debt Instrument [Line Items]
Notes payable and credit facility	$12,789,165		$7,574,822
Foreign revolving credit facilities [Member]
Debt Instrument [Line Items]
Notes payable and credit facility	34,141	[1]	20,205	[1]
Note payable - GCP note [Member]
Debt Instrument [Line Items]
Notes payable and credit facility	211,580	[2]	211,580	[2]
Keltic facility [Member]
Debt Instrument [Line Items]
Notes payable and credit facility	10,123,544	[3]	1,953,037	[3]
Bourbon term loan [Member]
Debt Instrument [Line Items]
Notes payable and credit facility	744,900	[4]	2,015,000	[4]
Junior loan [Member]
Debt Instrument [Line Items]
Notes payable and credit facility	0	[5]	1,250,000	[5]
5% Convertible notes [Member]
Debt Instrument [Line Items]
Notes payable and credit facility	$1,675,000	[6]	$2,125,000	[6]
[1]	The Company has arranged various facilities aggregating €303,657 or $329,471 (translated at the March 31, 2015 exchange rate) with an Irish bank, including overdraft coverage, creditorsb insurance, customs and excise guaranty, and a revolving credit facility. These facilities are payable on demand, continue until terminated by either party, are subject to annual review, and call for interest at the lenderbs AA1 Rate minus 1.70%. The balance on the credit facilities included in notes payable totaled €31,466 or $34,141 (translated at the March 31, 2015 exchange rate) and €14,693 or $20,205 (translated at the March 31, 2014 exchange rate), at March 31, 2015 and 2014, respectively.
[2]	In December 2009, GCP issued a promissory note (the bGCP Noteb) in the aggregate principal amount of $211,580 to Gosling's Export (Bermuda) Limited in exchange for credits issued on certain inventory purchases. The GCP Note matures on April 1, 2020, is payable at maturity, subject to certain acceleration events, and calls for annual interest of 5%, to be accrued and paid at maturity. At March 31, 2015 and 2014, $10,579 of accrued interest was converted to amounts due to affiliates. At March 31, 2015 and 2014, $211,580 of principal due on the GCP Note was included in long-term liabilities.
[3]	In August 2011, the Company and CB-USA entered into a loan agreement with Keltic Financial Partners II, LP (bKelticb), which, as amended, provides for availability (subject to certain terms and conditions) of a facility of up to $12.0 million (the bKeltic Facilityb) for the purpose of providing the Company with working capital.In September 2014, the Company and CB-USA entered into an Amended and Restated Loan and Security Agreement (the bAmended Agreementb) with ACF FinCo I LP (bACFb), as successor in interest to Keltic, in order to amend certain terms of the Keltic Facility and the Bourbon Term Loan (defined below). Among other changes, the Amended Agreement modified certain aspects of the existing Keltic Facility, including increasing the maximum amount of the Keltic Facility from $8,000,000 to $12,000,000 and increasing the inventory sub-limit from $4,000,000 to $6,000,000. In addition, the term of the Keltic Facility was extended from December 31, 2016 to July 31, 2019. The Keltic Facility interest rate was reduced to the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.25%. As of December 31, 2014, the Keltic Facility interest rate was 6.25%. The monthly facility fee was reduced from 1.00% per annum of the maximum Keltic Facility amount to 0.75%. In addition, the Amended Agreement contains EBITDA targets allowing for further interest rate reductions in the future. The Amended Agreement also modifies certain aspects of the EBITDA covenant that was contained in the previously existing loan and security agreement, dated as of August 19, 2011, as amended. The Company paid ACF an aggregate $120,000 amendment fee in connection with the execution of the Amended Agreement. In connection with the amendment, the Company and CB-USA entered into the following ancillary agreements: (i) a Reaffirmation Agreement with (a) certain officers of the Company and CB-USA, including John Glover, the Companybs Chief Operating Officer, T. Kelley Spillane, the Companybs Senior Vice President - Global Sales, and Alfred Small, the Companybs Senior Vice President, Chief Financial Officer, Treasurer and Secretary, (b) certain participants in the Bourbon Term Loan and (c) certain junior lenders to the Company, including Frost Gamma Investments Trust, an entity affiliated with Phillip Frost, M.D., a director and principal shareholder of the Company, Mark E. Andrews, III, a director of the Company and the Companybs Chairman, an affiliate of Richard J. Lampen, a director of the Company and the Companybs President and Chief Executive Officer, an affiliate of Glenn Halpryn, a director of the Company, Dennis Scholl, a former director of the Company, and Vector Group Ltd., a more than 5% shareholder of the Company, of which Richard Lampen is an executive officer and Henry Beinstein, a director of the Company, is a director, which, among other things, reaffirms the existing Validity and Support Agreements by and among each officer, the Company, CB-USA and ACF, as successor-in-interest to Keltic; (ii) an Amended and Restated Term Note (the "Term Note"); and (iii) an Amended and Restated Revolving Credit Note (the "Revolving Note"). In connection with the Amended Agreement, on September 22, 2014, ACF entered into an amendment to that certain Subordination Agreement, dated as of August 7, 2013 (as amended, the "Subordination Agreement"), by and among ACF, as successor-in-interest to Keltic, and certain junior lenders to the Company; neither the Company nor CB-USA is a party to the Subordination Agreement. The Company and CB-USA are referred to individually and collectively as the Borrower. The Borrower may borrow up to the maximum amount of the Keltic Facility, provided that the Borrower has a sufficient borrowing base (as defined under the Amended Agreement). For the year ended March 31, 2015, the Company paid interest at 6.5%, until such time as the interest was reduced to 6.25% in connection with the September 2014 amendment. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Keltic Facility. After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the Amended Agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Keltic Facility interest rate. There have been no Events of Default under the Keltic Facility. In addition to the fee in connection with the Amended Agreement, the Company paid a $40,000 commitment fee in connection with the first amendment, a $70,000 closing and commitment fee in connection with the second amendment and a $25,000 closing and commitment fee in connection with the third amendment. Keltic also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default). The Amended Agreement contains standard borrower representations and warranties for asset-based borrowing and a number of reporting obligations and affirmative and negative covenants. The Amended Agreement includes negative covenants that, among other things, restrict the Borrowerbs ability to create additional indebtedness, dispose of properties, incur liens and make distributions or cash dividends. At March 31, 2015, the Company was in compliance, in all respects, with the covenants under the Amended Agreement. At March 31, 2015 and 2014, $10,123,544 and $1,953,037, respectively, due on the Keltic Facility was included in long-term liabilities.
[4]	In March 2013, the Company and CB-USA entered into an inventory term loan of $2,496,000 (the "Bourbon Term Loan") that was used to purchase bourbon inventory on March 11, 2013. Unless sooner terminated in accordance with its terms, the Bourbon Term Loan matures on July 31, 2019. The Bourbon Term Loan interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%. For the year ended March 31, 2015, the Company paid interest of 7.5%. Interest is payable monthly in arrears, on the first day of every month on the average daily unpaid principal amount of the Bourbon Term Loan. After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the loan agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan, all accrued and unpaid interest thereon, and all fees, costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31, 2016. Keltic required as a condition to funding the Bourbon Term Loan that Keltic had entered into a participation agreement (the "Participation Agreement") providing for an initial aggregate amount of $750,000 of the Bourbon Term Loan to be purchased by junior participants. Certain related parties of the Company purchased a portion of these junior participations in the Bourbon Term Loan, including Frost Gamma Investments Trust ($500,000), Mark E. Andrews, III ($50,000) and an affiliate of Richard J. Lampen ($50,000) (amounts shown are initial purchase amounts). Under the terms of the Participation Agreement, the junior participants receive interest at the rate of 11% per annum. Neither the Company nor CB-USA is a party to the Participation Agreement. However, the Borrower is party to a fee letter (the "Fee Letter") with the junior participants (including the related party junior participants) pursuant to which the Borrower is obligated to pay the junior participants an aggregate commitment fee of $45,000 in three equal annual installments of $15,000. In August 2013, the Bourbon Term Loan was amended to provide the Company with the ability to increase the maximum aggregate principal amount of the Bourbon Term Loan from $2,500,000 to up to $4,000,000 to finance the purchase of aged whiskies following the identification of junior participants to purchase a portion of the increased Bourbon Term Loan amount. The balance on the Bourbon Term Loan included in notes payable totaled $744,900 and $2,015,000 at March 31, 2015 and 2014, respectively. In May 2015, the Bourbon Term Loan was paid in full in accordance with its standard terms in the normal course of business.
[5]	In August 2013, the Company entered into a Loan Agreement (the "Junior Loan Agreement"), by and between the Company and the lending parties thereto (the "Junior Lenders"), which provided for an aggregate $1,250,000 unsecured loan (the "Junior Loan") to the Company. The Junior Loan bore interest at a rate of 11% per annum, payable quarterly in arrears commencing November 1, 2013, and was set to mature on October 15, 2015. The Junior Loan Agreement provided for a funding fee of 2% per annum on the then outstanding Junior Loan balance (pro-rated for any period of less than one year), payable pro rata among the Junior Lenders on the date of the Junior Loan Agreement and on the first and second anniversaries thereof. The Junior Lenders included Frost Gamma Investments Trust ($200,000), Mark E. Andrews, III ($50,000) and an affiliate of Richard J. Lampen ($50,000) In September 2014, in connection with the Amended Agreement described in Note 8C, the Company used proceeds from the Keltic Facility to repay the $1,250,000 principal amount outstanding under the Junior Loan and all accrued and outstanding interest. At March 31, 2014, $1,250,000 of principal due on the Junior Loan was included in long-term liabilities.
[6]	In October 2013, the Company entered into a 5% Convertible Subordinated Note Purchase Agreement (the "Note Purchase Agreement") with the purchasers party thereto, under which the Company issued an aggregate initial principal amount of $2,125,000 of unsecured subordinated notes (the "Convertible Notes"). The Convertible Notes bear interest at a rate of 5% per annum, payable quarterly, until their maturity date of December 15, 2018. The Convertible Notes, and accrued but unpaid interest thereon, are convertible in whole or in part from time to time at the option of the holders thereof into shares of the Companybs common stock at a conversion price of $0.90 per share (the "Conversion Price"). The Convertible Notes may be prepaid in whole or in part at any time without penalty or premium, but with payment of accrued interest to the date of prepayment. The Convertible Notes contain customary events of default, which, if uncured, entitle each note holder to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the Convertible Notes. The purchasers of the Convertible Notes include related parties of the Company, including an affiliate of Dr. Phillip Frost ($500,000), Mark E. Andrews, III ($50,000), an affiliate of Richard J. Lampen ($50,000), an affiliate of Glenn Halpryn ($200,000), a director, Dennis Scholl ($100,000), a former director, and Vector Group Ltd. ($200,000). The Company may forcibly convert all or any part of the Convertible Notes and all accrued but unpaid interest thereon if (i) the average daily volume of the Companybs common stock (as reported on the principal market or exchange on which the common stock is listed or quoted for trading) exceeds $50,000 per trading day and (ii) the volume weighted average price of the common stock for at least twenty (20) trading days during any thirty (30) consecutive trading day period exceeds 250% of the then-current conversion price. Any forced conversion will be applied ratably to the holders of all Convertible Notes issued pursuant to the Note Purchase Agreement based on each holderbs then-current note holdings. In connection with the Note Purchase Agreement, each purchaser of the Convertible Notes was required to execute a joinder to the subordination agreement, by and among Keltic and certain other junior lenders to the Company; the Company is not a party to the Subordination Agreement. In the year ended March 31, 2015, Convertible Note holders converted $350,000 of Convertible Notes and $787 of accrued interest thereon into 389,676 shares of common stock. At March 31, 2015 and 2014, $1,675,000 and $2,125,000 of principal due on the Convertible Notes was included in long-term liabilities, respectively.

NOTES_PAYABLE_AND_CAPITAL_LEAS3

NOTES PAYABLE AND CAPITAL LEASE (Details 1) (USD $)	Mar. 31, 2015	Mar. 31, 2014
2016	$34,141
2017	0
2018	0
2019	1,675,000
2020	10,868,444
Thereafter	211,580
Total	$12,789,165	$7,574,822

NOTES_PAYABLE_AND_CAPITAL_LEAS4

NOTES PAYABLE AND CAPITAL LEASE (Details Textual)

12 Months Ended

12 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Mar. 31, 2015

Mar. 31, 2015

Sep. 30, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2009

Sep. 30, 2014

Dec. 31, 2014

Mar. 31, 2015

Mar. 31, 2014

Aug. 31, 2011

Sep. 30, 2014

Sep. 30, 2014

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Aug. 31, 2013

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Sep. 30, 2014

Sep. 30, 2014

Mar. 31, 2015

Mar. 31, 2015

USD ($)

EUR (€)

USD ($)

USD ($)

EUR (€)

USD ($)

Common Stock [Member]

Convertible Subordinated Debt [Member]

Convertible Notes Payable [Member]

GCP Note [Member]

GCP Note [Member]

GCP Note [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Irish Bank [Member]

Irish Bank [Member]

Bourbon Term Loan [Member]

Junior Loan [Member]

Junior Loan [Member]

Dr. Phillip Frost [Member]

Mark E. Andrews [Member]

Richard J. Lampen [Member]

Glenn Halpryn [Member]

Dennis Scholl [Member]

Vector Group Ltd. [Member]

Frost Gamma Investments Trust [Member]

Mark E Andrews Iii [Member]

Mark E Andrews Iii [Member]

Affiliate Of Richard J Lampen [Member]

Participation Agreement [Member]

Amendment Agreement [Member]

First Amendment [Member]

Second Amendment [Member]

Second Amendment [Member]

Second Amendment [Member]

Second Amendment [Member]

Third Amendment [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

EUR (€)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Junior Loan [Member]

USD ($)

Keltic Facility [Member]

Bourbon Term Loan [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Keltic Facility [Member]

Bourbon Term Loan [Member]

Keltic Facility [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Minimum [Member]

Maximum [Member]

USD ($)

USD ($)

USD ($)

Debt Instrument [Line Items]

Debt Instrument, Interest Rate At Period End

5.00%

Other Accrued Liabilities, Noncurrent

$10,579

$10,579

Notes Payable, Noncurrent

211,580

211,580

211,580

211,580

211,580

500,000

50,000

50,000

200,000

100,000

200,000

Line Of Credit Facility, Maximum Borrowing Capacity

12,000,000

329,471

303,657

8,000,000

12,000,000

Line Of Credit Facility, Interest Rate Description

interest rate was reduced to the rate that, when annualized, is the greatest of (a) the Prime Rate plus 3.00%, (b) the LIBOR Rate plus 5.50% and (c) 6.25%.

The monthly facility fee was reduced from 1.00% per annum of the maximum Keltic Facility amount to 0.75%

The Bourbon Term Loan interest rate is the rate that, when annualized, is the greatest of (a) the Prime Rate plus 4.25%, (b) the LIBOR Rate plus 6.75% and (c) 7.50%.

Debt Instrument, Debt Default, Description Of Violation Or Event Of Default

After the occurrence and during the continuance of any "Default" or "Event of Default" (as defined under the loan agreement), the Borrower is required to pay interest at a rate that is 3.25% per annum above the then applicable Bourbon Term Loan interest rate. The Borrower is required to pay down the principal balance of the Bourbon Term Loan within 15 banking days from the completion of a bottling run of bourbon from the bourbon inventory stock purchased on or about the date of the Bourbon Term Loan in an amount equal to the purchase price of such bourbon. The unpaid principal balance of the Bourbon Term Loan, all accrued and unpaid interest thereon, and all fees, costs and expenses payable in connection with the Bourbon Term Loan are due and payable in full on December 31, 2016.

Line Of Credit Facility, Commitment Fee Amount

40,000

70,000

25,000

Debt Instrument, Interest Rate During Period

0.00%

6.50%

Line Of Credit, Current

34,141

31,466

20,205

14,693

Line Of Credit Facility, Interest Rate During Period

3.25%

1.70%

1.70%

Term Loan

744,900

2,015,000

2,496,000

500,000

50,000

50,000

50,000

750,000

Commitment Fee Payable

45,000

Commitment Fee Annual Installment Amount

15,000

Unsecured debt

2,125,000

Debt Instrument, Interest Rate, Stated Percentage

11.00%

Long-term Debt, Gross

10,123,544

1,953,037

2,500,000

4,000,000

Debt Instrument, Convertible, Conversion Price

$0.90

Debt Instrument, Convertible, If-converted Value in Excess of Principal

50,000

Debt Instrument, Convertible, Threshold Consecutive Trading Days

20 days

Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger

250.00%

Subordinated Borrowing, Interest Rate

5.00%

Convertible Notes Payable, Noncurrent

1,675,000

2,125,000

Other Notes Payable, Noncurrent

0

1,250,000

1,250,000

1,250,000

Line of Credit Facility, Asset Restrictions

4,000,000

6,000,000

Line of Credit Facility, Amendment Fees, Amount

120,000

Stock Issued During Period, Value, Conversion of Convertible Securities

350,000

Stock Issued During Period, Shares, Conversion of Convertible Securities

501,574

389,676

Annual Facility Fee Receivables Description

Keltic also receives a collateral management fee of $1,000 per month (increased to $2,000 after the occurrence of and during the continuance of an Event of Default).

Debt Instrument, Increase, Accrued Interest

$787

EQUITY_Details_Textual

EQUITY (Details Textual) (USD $)	12 Months Ended		5 Months Ended	1 Months Ended	3 Months Ended	0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Nov. 30, 2013	Jun. 30, 2014	Feb. 24, 2014	Feb. 11, 2014
Class of Stock [Line Items]
Proceeds from Issuance of Common Stock	$3,319,915	$4,531,643
Stock Issued During Period, Value, New Issues	3,133,568	4,347,302
Payments of Stock Issuance Costs	186,347	184,341
Preferred Stock, Par Or Stated Value Per Share (in dollars per share)	$0.01	$0.01	$0.01
Stock Issued During Period, Value, Conversion of Convertible Securities	350,000
Convertible Note One [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities	350,000
Stock Issued During Period, Shares, Conversion of Convertible Securities	389,676
Debt Conversion, Original Debt, Interest Amount	787
Convertible Note Two [Member]
Class of Stock [Line Items]
Stock Issued During Period, Value, Conversion of Convertible Securities	350,000
Stock Issued During Period, Shares, Conversion of Convertible Securities	389,676
Debt Conversion, Original Debt, Interest Amount	787
Distribution Agreement [Member]
Class of Stock [Line Items]
Compensation Percentage	2.00%
Distribution Agreement 2014 [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Common Stock	10,000,000
Intercompany Agreements, Description	Also, the Company will reimburse Barrington for certain expenses incurred in connection with the matters contemplated by the 2014 Distribution Agreement, up to an aggregate of $50,000, plus up to an additional $7,500 per calendar quarter related to ongoing maintenance; provided, however, that such reimbursement amount shall not exceed 8% of the aggregate gross proceeds received by the Company under the 2014 Distribution Agreement.
Stock Issued During Period, Shares, New Issues			1,290,581
Stock Issued During Period, Value, New Issues			2,088,674
Payments of Stock Issuance Costs			122,149
Distribution Agreement 2013 [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues					1,247,343
Stock Issued During Period, Value, New Issues				6,000,000	1,231,241
Payments of Stock Issuance Costs					64,198
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Dividend Rate, Percentage	10.00%
Dividends, Preferred Stock, Stock		$384,599
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Conversion of Stock, Shares Converted						25,760,881	1,704,729
Preferred Stock, Par Or Stated Value Per Share (in dollars per share)	$0.01		$0.01
Preferred Stock, Dividend Rate, Per-Dollar-Amount	$1,000
Preferred Stock, Shares Outstanding						6,271	430

PROVISION_FOR_INCOME_TAXES_Det

PROVISION FOR INCOME TAXES (Details) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Provision For Income Taxes [Line Items]
Federal, Current	$608,589	$0
Federal, Deferred	214,958	-550,482
Federal, Total	823,547	-550,482
State and Local, Current	382,232	31,068
State and Local, Deferred	73,220	-71,000
State and Local, Total	455,452	-39,932
Total, Current	990,821	31,068
Total, Deferred	288,178	-590,414
Total	$1,278,999	($590,414)

PROVISION_FOR_INCOME_TAXES_Det1

PROVISION FOR INCOME TAXES (Details 1)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Provision For Income Taxes [Line Items]
Computed expected tax benefit, at 34%	-34.00%	-34.00%
Permanent items	3.10%	0.80%
Change in valuation allowance	78.30%	5.80%
Net change in fair value of warrant liability	0.00%	25.20%
Effect of foreign rate differential	1.80%	0.50%
Taxes included in minority interest	14.70%	-0.30%
Intercompany profit	2.60%	-0.50%
Other	3.50%	3.10%
State and local taxes, net of federal benefit	-11.70%	-7.46%
Income tax expense (benefit)	58.30%	-6.86%

PROVISION_FOR_INCOME_TAXES_Det2

PROVISION FOR INCOME TAXES (Details 2) (USD $)	Mar. 31, 2015	Mar. 31, 2014
Deferred income tax assets:
Foreign currency transactions	$74,000	$72,000
Accounts receivable	5,000	5,000
Inventory	518,000	304,000
Stock based compensation	2,440,000	2,125,000
Amortization of intangibles	0	206,000
Net operating loss carryforwards B U.S.	32,676,000	32,186,000
Net operating loss carryforwards B foreign	1,990,000	1,974,000
Other	2,000	2,000
Total gross assets	37,705,000	36,874,000
Less: Valuation allowance	-37,668,000	-36,401,000
Net deferred asset	37,000	473,000
Deferred income tax liability:
Intangible assets acquired in acquisition of subsidiary	-629,444	-629,444
Intangible assets acquired in investment in GCP	-740,708	-888,863
Net deferred income tax liability	($1,370,152)	($1,518,307)

PROVISION_FOR_INCOME_TAXES_Det3

PROVISION FOR INCOME TAXES (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Provision For Income Taxes [Line Items]
Operating Loss Carryforwards		$2,520,000
Deferred Tax Liabilities, Intangible Assets	629,444	629,444
Deferred Income Tax Expense Benefit Period Of Recognition	15 years
Deferred Income Tax Expense (Benefit)	288,178	-590,414
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	1,267,000	258,000
Deferred Tax Assets, Net, Current	37,000	473,330
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount		2,520,000
General and Administrative Expense [Member]
Provision For Income Taxes [Line Items]
Income Tax Examination, Penalties and Interest Expense	19,501
Domestic Tax Authority [Member]
Provision For Income Taxes [Line Items]
Operating Loss Carryforwards	80,200,000
Operating Loss Carryforwards Expiration Period	2035
Foreign Tax Authority [Member]
Provision For Income Taxes [Line Items]
Operating Loss Carryforwards	19,900,000
Income (Loss) from Continuing Operations before Income Taxes, Foreign	$90,466	$168,233

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Details) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Outstanding and expected to vest at end of period	11,988,188
Shares, Exercisable at period end	7,064,133
Weighted Average Exercise Price, Exercisable at period end	$0.49
Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Outstanding at beginning of year	11,174,007	8,120,765
Shares, Granted	2,525,000	3,300,000
Shares, Exercised	-677,127	-80,758
Shares, Forfeited	-1,033,692	-166,000
Shares, Outstanding and expected to vest at end of period	11,988,188	11,174,007
Shares, Exercisable at period end	7,064,133	5,511,447
Weighted Average Exercise Price, Outstanding at beginning of year	$0.51	$0.64
Weighted Average Exercise Price, Granted	$1.04	$0.43
Weighted Average Exercise Price, Exercised	$0.33	$0.32
Weighted Average Exercise Price, Forfeited	$1.10	$5.79
Weighted Average Exercise Price, Outstanding and expected to vest at end of period	$0.58	$0.51
Weighted Average Exercise Price, Exercisable at period end	$0.49	$0.63
Weighted average fair value of grants during the period	$0.65	$0.26

STOCKBASED_COMPENSATION_Detail1

STOCK-BASED COMPENSATION (Details 1) (USD $)	12 Months Ended
	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	11,988,188
Options, Outstanding, Weighted Average Remaining Life in Years	6 years 8 months 23 days
Options Exercisable, Shares	7,064,133
Options, Exercisable, Weighted Average Exercise Price	$0.49
Aggregate Intrinsic Value	$7,223,132
Stock Options One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	580,300
Options, Outstanding, Weighted Average Remaining Life in Years	3 years 7 months 6 days
Options Exercisable, Shares	580,300
Options, Exercisable, Weighted Average Exercise Price	$0.22
Aggregate Intrinsic Value	682,957
Range of Excercise Prices, Lower Limit	$0.01
Range of Excercise Prices, Upper Limit	$0.25
Stock Options Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	8,532,888
Options, Outstanding, Weighted Average Remaining Life in Years	6 years 3 months 11 days
Options Exercisable, Shares	6,076,833
Options, Exercisable, Weighted Average Exercise Price	$0.34
Aggregate Intrinsic Value	6,470,305
Range of Excercise Prices, Lower Limit	$0.26
Range of Excercise Prices, Upper Limit	$0.40
Stock Options Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	2,741,000
Options, Outstanding, Weighted Average Remaining Life in Years	9 years 18 days
Options Exercisable, Shares	273,000
Options, Exercisable, Weighted Average Exercise Price	$1.26
Aggregate Intrinsic Value	69,870
Range of Excercise Prices, Lower Limit	$1.01
Range of Excercise Prices, Upper Limit	$2
Stock Options Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	17,000
Options, Outstanding, Weighted Average Remaining Life in Years	1 year 11 months 26 days
Options Exercisable, Shares	17,000
Options, Exercisable, Weighted Average Exercise Price	$6.36
Aggregate Intrinsic Value	0
Range of Excercise Prices, Lower Limit	$6.01
Range of Excercise Prices, Upper Limit	$7
Stock Options Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	109,500
Options, Outstanding, Weighted Average Remaining Life in Years	1 year 2 months 16 days
Options Exercisable, Shares	109,500
Options, Exercisable, Weighted Average Exercise Price	$7.57
Aggregate Intrinsic Value	0
Range of Excercise Prices, Lower Limit	$7.01
Range of Excercise Prices, Upper Limit	$8
Stock Options Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Outstanding, Shares	7,500
Options, Outstanding, Weighted Average Remaining Life in Years	1 year 10 months 10 days
Options Exercisable, Shares	7,500
Options, Exercisable, Weighted Average Exercise Price	$9
Aggregate Intrinsic Value	$0
Range of Excercise Prices, Lower Limit	$8.01
Range of Excercise Prices, Upper Limit	$9

STOCKBASED_COMPENSATION_Detail2

STOCK-BASED COMPENSATION (Details 2) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Shares, Unvested at beginning of the year	5,662,560	3,871,807
Shares, Granted	2,525,000	3,300,000
Shares, Canceled or expired	-954,083	-10,000
Shares, Vested	-2,309,422	-1,499,247
Shares, Unvested at end of the year	4,924,055	5,662,560
Weighted Average Exercise Price, Unvested at beginning of the year	$0.32	$0.32
Weighted Average Exercise Price, Granted	$1.04	$0.43
Weighted Average Exercise Price, Canceled or expired	$0.44	$0.32
Weighted Average Exercise Price, Vested	$0.41	$0.32
Weighted Average Exercise Price, Unvested at end of the year	$0.70	$0.32

STOCKBASED_COMPENSATION_Detail3

STOCK-BASED COMPENSATION (Details 3)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Expected dividend yield	0.00%	0.00%
Maximum [Member]
Risk-free interest rate	1.76%	1.85%
Expected option life in years	6 years 3 months	6 years 3 months
Expected stock price volatility	77.00%	76.00%
Minimum [Member]
Risk-free interest rate	1.47%	0.86%
Expected option life in years	5 years 6 months	5 years 6 months
Expected stock price volatility	74.00%	65.00%

STOCKBASED_COMPENSATION_Detail4

STOCK-BASED COMPENSATION (Details 4) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Expected dividend yield	0.00%	0.00%
Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Stock price	0.92
Risk-free interest rate	0.61%
Expected option life in years	2 years 7 months 17 days
Expected stock price volatility	55.00%
Expected dividend yield	0.00%

STOCKBASED_COMPENSATION_Detail5

STOCK-BASED COMPENSATION (Details 5) (Warrant [Member], USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Warrant [Member]
Warrants, Outstanding and exercisable, at beginning of period	1,777,802	11,904,925
Warrants, Granted	0	0
Warrants, Exercised	0	-10,127,123
Warrants, Forfeited	-1,657,802	0
Warrants, Outstanding and exercisable, at end of period	120,000	1,777,802
Weighted Average Exercise Price Per Warrant, Outstanding and exercisable at beginning of period	$0.90	$0.46
Weighted Average Exercise Price Per Warrant, Granted	$0	$0
Weighted Average Exercise Price Per Warrant, Exercised	$0	$0.38
Weighted Average Exercise Price Per Warrant, Forfeited	$0.38	$0
Weighted Average Exercise Price Per Warrant, Outstanding and exercisable at end of period	$8	$0.90

STOCKBASED_COMPENSATION_Detail6

STOCK-BASED COMPENSATION (Details Textual) (USD $)	1 Months Ended		12 Months Ended		1 Months Ended
	Oct. 31, 2011	Jun. 30, 2011	Mar. 31, 2015	Mar. 31, 2014	Apr. 02, 2014	Jul. 31, 2003	Jan. 31, 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-Based Compensation Expense (in dollars)			$787,710	$393,914
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized (in dollars)			1,608,518
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1			2 years 2 months 19 days
Employee Service Number Of Share Based Compensation Non vested Awards Total Compensation Cost Not Yet Recognized Stock Options			4,924,055
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number			7,064,133
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price			$0.49
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			6 years 8 months 23 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term			5 years 6 months 22 days
Warrant Liability Outstanding			6,187,968
Weighted Average Exercise Price Fair Market Value Per Warrant Exercised			$0.50
Weighted Average Exercise Price Fair Market Value Per Warrant Unexercised			$0
Warrants Issued At Fair Value	780,972	487,022
Change In Unrealized Gain Loss On Fair Value Warrants			5,392,594
Proceeds from Warrant Exercises			598,715	3,848,332
Selling Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-Based Compensation Expense (in dollars)			178,137	81,567
General and Administrative Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated Share-Based Compensation Expense (in dollars)			609,573	312,347
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Exercised Number			0	-10,127,123
Warrants Forfeited Number			-1,657,802	0
Series A Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Exercise Price			$0.38
Warrants Exercisable Period			five years
Convertible Preferred Stock, Terms of Conversion			The exercise price of the 2011 Warrants was equal to 125% of the conversion price of the Series A Preferred Stock.
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			677,127	80,758
Warrants 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number Of Warrants Forfeited					1,657,802
Proceeds from Warrant Exercises			$629,965
Number Of Securities Called By Warrants For Forfeiture			1,657,802
Conversion Of Warrants Shares Issued			1,657,802
Warrants Exercised Number				10,127,123
Warrants Forfeited Number				1,543,214
Stock Incentive Plan 2003 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			2,779,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period						10 years
Stock Incentive Plan 2003 [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period						3 years
Stock Incentive Plan 2003 [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							12,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period						5 years
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Goods and Nonemployee Services Transaction, Shares Approved for Issuance			7,221,000

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details Textual) (USD $)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Related Party Transaction [Line Items]
Due from Related Parties	$511,146	$229,557
Pallini [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Purchases from Related Party	3,840,446	3,467,812
Pallini [Member] | Marketing Expense [Member]
Related Party Transaction [Line Items]
Due from Related Parties	138,750	115,288
Vector Group [Member]
Related Party Transaction [Line Items]
Annual Fees for Services Related Party	100,000
Vector Group [Member] | General and Administrative Expense [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party	135,475	104,746
Ladenburg Thalmann Financial Services Inc [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Expenses from Transactions with Related Party	$210,875	$126,000

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	Mar. 31, 2015
Years ending March 31,
2016	$289,379
2017	70,012
2018	42,546
2019	10,742
Total	$412,679

COMMITMENTS_AND_CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Textual)

12 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

Mar. 31, 2015

USD ($)

USD ($)

New York [Member]

Dublin [Member]

Dublin [Member]

Houston, Tx [Member]

Four Contract Year [Member]

Twelve Contract Year [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

Irish Whiskey [Member]

USD ($)

USD ($)

EUR (€)

USD ($)

Four Contract Year [Member]

Four Contract Year [Member]

Four Contract Year One [Member]

Four Contract Year One [Member]

Twelve Contract Year [Member]

Twelve Contract Year [Member]

Twelve Contract Year One [Member]

Twelve Contract Year One [Member]

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

EUR (€)

USD ($)

EUR (€)

Supply Commitment [Line Items]

Long-term Purchase Commitment, Amount

$840,516

€ 774,662

$904,544

€ 833,673

$329,841

€ 303,998

$373,012

€ 343,787

Operating Leases, Income Statement, Contingent Revenue

19,975

1,194

1,100

3,440

Long Term Purchase Commitment Percentage Agreed To Purchase

90.00%

80.00%

Bulk Irish whiskey Purchased

791,551

729,533

236,386

217,865

Contract Year Ending

30-Jun-15

30-Jun-15

30-Jun-15

30-Jun-15

Lease Expiration Date

30-Apr-16

31-Oct-16

31-Oct-16

26-Jun-18

Operating Leases, Rent Expense

359,714

356,280

Payments Under Contingent Consideration Agreements

$0

$5,940

CONCENTRATIONS_Details_Textual

CONCENTRATIONS (Details Textual)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Concentration Risk [Line Items]
Concentration Risk, Percentage	100.00%	100.00%
Customer Concentration Risk [Member] | Sales Revenue, Goods, Net [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	29.70%	31.90%
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	30.10%	35.10%

GEOGRAPHIC_INFORMATION_Details

GEOGRAPHIC INFORMATION (Details) (USD $)	12 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Consolidated Sales, net:
Total Consolidated Sales, net	$57,457,421	[1]	$48,140,483	[1]
Concentration Risk, Percentage	100.00%		100.00%
Consolidated Income (Loss) from Operations:
Total Consolidated Loss from Operations	-1,077,905		-1,319,833
Operating Income (Loss), Percentage	100.00%		100.00%
Consolidated Net Loss Attributable to Controlling Interests:
Total Consolidated Net Loss Attributable to Controlling Interests	-3,799,742		-8,906,747
Net Income (Loss) Attributable To Common Shareholders	100.00%		100.00%
Income tax (expense) benefit, net:
Income tax (expense) benefit, net:	-1,278,999		590,414
Consolidated Assets:
Total Consolidated Assets	44,038,940		36,521,510
Assets Percentage	100.00%		100.00%
International [Member]
Consolidated Sales, net:
Total Consolidated Sales, net	7,938,393		7,305,516
Concentration Risk, Percentage	13.80%		15.20%
Consolidated Income (Loss) from Operations:
Total Consolidated Loss from Operations	17,172		-266
Operating Income (Loss), Percentage	-1.60%		0.00%
Consolidated Net Loss Attributable to Controlling Interests:
Total Consolidated Net Loss Attributable to Controlling Interests	-101,453		-153,419
Net Income (Loss) Attributable To Common Shareholders	2.70%		1.70%
Consolidated Assets:
Total Consolidated Assets	2,052,583		2,201,343
Assets Percentage	4.70%		6.00%
United States [Member]
Consolidated Sales, net:
Total Consolidated Sales, net	49,519,028		40,834,967
Concentration Risk, Percentage	86.20%		84.80%
Consolidated Income (Loss) from Operations:
Total Consolidated Loss from Operations	-1,095,077		-1,319,567
Operating Income (Loss), Percentage	101.60%		100.00%
Consolidated Net Loss Attributable to Controlling Interests:
Total Consolidated Net Loss Attributable to Controlling Interests	-3,698,289		-8,753,328
Net Income (Loss) Attributable To Common Shareholders	97.30%		98.30%
Income tax (expense) benefit, net:
Income tax (expense) benefit, net:	-1,278,999		590,414
Income tax (expense) benefit, net: Percentage	100.00%		100.00%
Consolidated Assets:
Total Consolidated Assets	41,986,357		34,320,167
Assets Percentage	95.30%		94.00%
Rum [Member]
Consolidated Assets:
Total Consolidated Assets	16,998,034		16,643,640
Assets Percentage	29.60%		34.60%
Whiskey [Member]
Consolidated Assets:
Total Consolidated Assets	19,147,028		13,521,875
Assets Percentage	33.30%		28.10%
Liqueurs [Member]
Consolidated Assets:
Total Consolidated Assets	8,756,376		8,992,277
Assets Percentage	15.20%		18.70%
Vodka [Member]
Consolidated Assets:
Total Consolidated Assets	2,413,994		2,852,956
Assets Percentage	4.20%		5.90%
Tequila [Member]
Consolidated Assets:
Total Consolidated Assets	208,845		218,552
Assets Percentage	0.40%		0.50%
Wine [Member]
Consolidated Assets:
Total Consolidated Assets	0		284,806
Assets Percentage	0.00%		0.60%
Related Non-Alcoholic Beverage Products [Member]
Consolidated Assets:
Total Consolidated Assets	$9,933,144		$5,626,377
Assets Percentage	17.30%		11.60%
[1]	Sales, net and Cost of sales include excise taxes of $6,754,453 and $6,420,730 for the years ended March 31, 2015 and 2014, respectively.

SUBSEQUENT_EVENTS_Details_Text

SUBSEQUENT EVENTS (Details Textual) (USD $)	12 Months Ended		1 Months Ended	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2015	Jun. 11, 2015
Proceeds from Issuance of Common Stock	$3,319,915	$4,531,643
Payments of Stock Issuance Costs	186,347	184,341
Subsequent Event [Member] | Copperhead Distillery Company [Member]
Payments to Acquire Investments			500,000
Purchase Price Of Investments Percentage			20.00%
Subsequent Event [Member] | Distribution Agreement [Member]
Stock Issued During Period, Shares, New Issues				633,209
Proceeds from Issuance of Common Stock				1,040,541
Payments of Stock Issuance Costs				$20,870